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ANOTHER REASON TO REFORM THE
FEDERAL REGULATORY SYSTEM:
AGENCIES' TREATING NONLEGISLATIVE
RULES AS BINDING LAW
Abstract: This Note analyzes the nonlegislative rule exception to the
rulemaking requirements of the Administrative Procedure Act
("APA'). To lend greater accountability to federal agencies, the APA
places an obligation on agencies to incorporate public input when
creating new rules. Agencies, however; can avoid considering public
commentary through a vague exception: section 553(b)(A) of the
APA. After analyzing section 553(b)(A), this. Note evaluates how
one agency, the Food and Drug Administration, has responded to the
confusion surrounding the exception. Finally, this Note considers
how the Senate has overlooked problems associated with section
553(b)(A) in the Senate's most recent bill to revise administrative
procedures.
INTRODUCTION
Congress creates administrative agencies to execute many of the
statutes it enacts. When establishing an agency, Congress grants it sev-
eral powers, such as the authority to perform investigations, to con-
duct adjudications and, most pertinent to this Note, to adopt rules.
Generally, agencies create two types of rules: legislative rules and non-
legislative rules. Legislative rules, better known as "regulations," have
the force of law. The government and the public must conform to the
dictates of legislative rules, as if they were statutes. Conversely, non-
legislative rules lack the force of law. Rather, they represent recom-
mendations and advice. Nonlegislative rules have innumerable syno-
nyms, such as interpretative rules, statements of policy, rules of agency
organization and guidelines.
Congress briefly addresses legislative and nonlegislative rules in
the Administrative Procedure Act ("APA"). 1 In 1946, Congress passed
the APA to foster clarity, uniformity and public participation in the
I.SceAdtitinistrathT Procedure Act, 5 U.S.C. § 553 (1994).
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administrative state. To further those worthy goals, the APA prescribes
procedures that agencies must follow when exercising their powers.
For instance, the APA explains how agencies develop legislative
rules. According to the APA, to produce legislative rules, agencies
must follow a procedure incorporating public input. On the other
hand, to create nonlegislative rules, agencies need not follow any pre-
scribed procedure and need not regard public commentary. Thus, a
dichotomy exists: created after a process incorporating public input,
legislative rules possess the full force of the law; created without any
formal process, nonlegislative rules lack the force of law.
Distinguishing between legislative and nonlegislative rules, how-
ever, is not always clean Courts have described the difference between
legislative and nonlegislative rules as "tenuous," "enshrouded in con-
siderable smog" and "fuzzy."2 The difference between legislative and
nonlegislative rules becOmes confused when agencies treat nonlegisla-
tive rules as if they bear the force of law—as if they were legislative
rules. When an agency views a nonlegislative rule as binding law, sev-
eral unwanted situations can occur.
For example, an agency creates a prudent safety standard by
adopting a nonlegislative rule. Although the standard protects public
health, a private party may ignore the standard. If the agency com-
mences legal action against that party for violating the nonlegislative
rule, a court may dismiss the action because the rule lacks the force of
law. Thus, by employing the improper type of rule—nonlegislative
rather than legislative—the agency fails to protect public health. Al-
ternately, private parties may defer to the agency's nonlegislative rule
because they do not realize that nonlegislative rules lack the force of
law or because they wish to avoid provoking the agency into investigat-
ing them. Thus, while some companies follow the safety standard,
others may ignore it without suffering penalties. Also, a misguided
court may concur with the agency and uphold the enforcement ac-
tion. In any event, by treating the nonlegislative rule as binding law,
the agency creates inconsistency, unfairness and confusion.
Additionally, an agency will constrain its own discretion by treat-
ing a nonlegislative rule as binding law. A private company may
closely follow the agency's safety standard. Other parties, however,
fear that the standard is too lenient and that the company is endan-
2See Community Nutrition Inst. v. Young, 818 F.2d 943, 946 (D.C. Cir. 1987) (quoting
Chisholm v. FCC, 538 F.2d 349, 393 (D.C. Cir. 1976); Noel v. Chapman, 508 F.2d 1023,
1030 (2d Cir. 1975); Pacific Gas 84 Elec. Co. v. Federal Power C01111/1'11, 506 F.2d 33, 37
(D.C. Cir. 1974)).
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gering public health, so they petition the agency to take action against
the company. The agency probably would be reluctant to take any ac-
tion. Even if the agency chose to act, a court may hold that the agency
is estopped from initiating enforcement proceedings because the
company conformed to the rule. Here, public health suffers because
an agency treated a nonlegislative rule as law. Moreover, the above
examples illustrate situations in which the public and the government
follow rules created without public involvement, thereby negating the
democratic nature of the APA.
This Note argues that by treating nonlegislative rules as binding
law, agencies undermine the APA's propitious objectives of clarity,
uniformity and public participation. 3 Part I of this Note provides
background relating to the APA, rulemaking procedures, legislative
rules and nonlegislative rules. 4 Part II focuses on the different legal
effects of legislative versus nonlegislative rules. 5 Part III addresses one
agency's current attempt to revise the role of nonlegislative rules and
a bill presently in Congress aimed at regulatory reform. 6 Specifically,
Part III evaluates the Food and Drug Administration's Good Guid-
ance Practices and the Senate's proposed Regulatory Improvement
Act of 1999.7 Filially, this Note argues that Congress and administra-
tive agencies should clarify the confusion surrounding nonlegislative
rules and should ensure that agencies do not treat nonlegislative rules
as binding law. 8
I. THE ADMINISTRATIVE PROCEDURE ACT
In 1789, the first Congress of the United States enacted statutes
creating the nation's original administrative agencies, such as the Post
Office and the Treasury. 9 Subsequently, Congress has created innu-
merable agencies and granted them several powers, including the
3 .5re, e.g., 5 U.S.C. § 553; White v. Shalala, 7 F.3d 296, 303 (2d Cir. 1993); UNITED
STATES DEP'T OF JUSTICE, ATTORNEY GENERAL'S MANUAL ON THE ADMINISTRATIVE PROCE-
DURE ACT 9 (1947, Win. W. Gaunt & Sons, Inc., unabridged republication 1979).
4See infra notes 9-112 and accompanying text.
5See infra notes 113-63 and accompanying text.
6Sce infra notes 164-293 and accompanying text.
7See infra notes 164-293 and accompanying text.
5See infra notes 164-293 and accoinpanying text.
5See. e.g., I KENNETH CULP DAVIS & RICHARD J. PIERCE, JR., ADMINISTRATIVE LAW
TREATISE 7 (3d ed. 1994); JERRY L. MASHAW ET AL., ADMINISTRATIVE LAW: THE AMERICAN
PUBLIC LAW SYSTEM 4 (4th ed. 1998); J. SANDERS, EVOLUTION OF EXECUTIVE DEPART-
MENTS OF THE CONTINENTAL CONGRESS 1774-89, at 187-92 (1935).
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authority to make law. 1° Congress creates federal agencies through
legislative acts, commonly known as "organic" or "enabling" statutes,"
Through an organic statute, Congress grants an agency several pow-
ers, such as the authority to conduct adjudications, to investigate pri-
vate entities, to initiate enforcement actions and to create legislative
rules. 12 Each organic statute is unique, and over a century and a half,
the heterogeneity between the various agencies led to inconsistency
and confusion. 13
 Furthermore, many members of the public lamented
that it was undemocratic for administrative agencies to function with-
out regard for public opinion."
In 1946, Congress passed the Administrative Procedure Act
("APA") to promote uniformity, fairness and public participation in
how agencies operate. 15 For all intents and purposes, the APA is the
bible of administrative law." An agency must abide by both its organic
statute and the APA. 17 When a court reviews an agency's actions, the
oSee United States v. thimaud, 220 U.S. 506, 517 (1910) (noting that Congress may
delegate rulemaking authority to agencies); National Petroleum Refiners Ass'n v. FTC, 482
F.2d 672, 678 (D.C. Cir. 1973) (upholding FTC's authority to create legislative-type rules);
DAVIS & PIERCE, supra note 9, at 6 (size and scope of agency activity has increased during
every period of U.S. history); MASHAW ET AL., supra HOW 9, at 4-6, 15 (noting that Con-
gress has created many agencies and delegated to them rulemaking authority and other
powers).
"SeeSe  MASHAW ET AL., supra note 9, at 56 (stating: "Eviirtually all agency action begins
with a statute"); Rim-LARD J. PIERCE, JR. ET AL., ADMINISTRATIVE LAW AND PROCESS 35, 220
(1985) (noting that enabling statutes, also referred to as "organic," convey powers to agen-
cies); Stephen F. Williams, The Era of "Risk-Risk" and the Problem of Keeping the APA up to Date,
63 U. Cm. L. REv. 1375, 1384 (1996). Statutes, however, are not the only means by which
an agency comes into being. See MASHAW ET AL., supra note 9, at 12. Presidential executive
orders have created many federal agencies, such as the Environmental Protection Agency
and the Army Corps of Engineers. See id.
I 2 See Administrative Procedure Act, 5 U.S.C. §§ 551, 553-557 (1994); MASHAW ET AL.,
supra note 9, at 13-15.
15 See JAMES WILLARD HURST, LAW AND SOCIAL ORDER IN THE UNITED STATES 150-51
(1977) (noting the growth of administrative state fostered fragmentation of policy mak-
Mg).
mee	 141A SHAW ET AL., supra note 9, at 9.
"See 5 U.S.C. §§ 553-557 (codifying method for rulemaking and for judicial review of
agency action); White v. Shalala, 7 Fid 296, 303 (2d Cir. 1993) (noting that the APA in-
vests unrepresentative agencies with public participation and fairness); 11LISHAW ET AL.,
supra note 9, at 148 (noting that the APA systematized agency procedures); U.S. DEP'T OF
JUSTICE, supra note 3, at 9 (nothing that the purposes of APA are to provide for public
participation, public awareness, uniformity and judicial review of agency actions). For a
history of the APA, see generally Peter L. Strauss, Changing Times: the AIM at Fifty, 63 U.
Cm. L. REV. 1389 (1996).
16See 5 U.S.C. §§ 551, 553-596, 701-706; MASHAW ET AL., supra note 9, at 148; U.S.
DEP'T OF JUSTICE, supra note 3, at 9-10.
"SeeMASHAW ET AL., Silpra Dote 9, at 148; U.S. DEFT OF JUSTICE, supra note 3, at 9-10.
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court looks first to the agency's organic statute and second to the APA
as the default statute. 18 When Congress drafts organic statutes, it often
instructs agencies to follow certain provisions of the APA. 19 For in-
stance, many organic statutes defer to the APA's standardized rules for
rulemaking. 2°
The APA describes the procedure by which agencies may create
legislative rules. 21 According to the APA, to produce a legislative rule,
an agency must follow a procedure incorporating public input. 22 Be-
cause they require agencies to consider public commentary, rulemak-
ing procedures impose burdens on administrative agencies. 23 To allow
flexibility, the APA provides exceptions that release agencies from fol-
lowing any rulemaking procedure. 24 One exception, the focal point of
this Note, is for nonlegislative rules under § 553(b) (A) of the AF1A. 23
18See MASHAW ET AL., supra note 9, at 459; PIERCE ET AL., supra note 11, at 37; U.S.
DEP'T OF JUSTICE, supra note 3, at 9-10.
'nee MASHAW ET AL., supra note 9, at 459.
"See id.
21 ,See 5 U.S.C. § 553. Courts tend to treat interpretative rules, policy statements, guide-
lines and their ilk as virtually the same. See Community Nutrition Inst. v. Young, 818 F.2d
943, 945 (D.C. Cir. 1987) [hereinafter "CNI"]; see also Syncor Int'l Corp. v. Shalala, 127 F.3d
90, 93-94 (D.C. Cir. 1997) (stating that "[f]tu-ther confusing the matter is the tendency of
courts and litigants to lump interpretative rules and policy statements together in contrast
to substantive rules, a tendency to which we have ourselves succumbed on occasion."). In
the last few years, the District of Columbia Circuit Court of Appeals has stressed the differ-
ences between interpretative rules and policy statements. See Hudson v. Federal Aviation
Admin., 192 F.3d 1031, 1036 (D.C. Cir. 1999); Syncor, 127 F.3d at 94. Some legal scholars
have analyzed all nonlegislative rules as being similar, while others have found interpreta-
tive rules and policy statements to be quite distinct. Compare Robert A. Anthony, Interpreta-
tive Rules, Policy Statements, Guidances, Manuals, and the Like—Should Federal Agencies Use Them
to Bind the Public?, 41 DUKE L.J. 1311, 1323-27 (1992) [hereinafter Interpretative Rules] (ana-
lyzing interpretative rules and policy statements as completely different legal instruments),
with Ronald M. Levin, Nonlegislative Rules and the Administrative Open Mind, 41 DUKE L.J.
1497, 1499 (1992) (stating; "the proper distinction to be drawn here is between legislative
rules and nonlegislative rules ...."). This Note will not explore extensively all of the
nuances between the two types of nonlegislative rules.
22See, e.g., 5 U.S.C. §§ 553, 556-557;	 7 F.3d at 303.
25See Anthony, Interpretative Rules, supra note 21, at 1319; Richard M. Thomas, Prosecuto-
rial Discretion and Agency Self-Regulation: CNI a lining and the Aflatoxin Dance, 44 ADMIN. L.
'Rix. 131, 134 (1902).
24See 5 U.S.C. § 553(a), (b) (A), (b) (B).
"This Note will refer to the statutory provision as "5 U.S.C. § 553(b) (A)." Because the
statute's format is ambiguous, however, many courts and scholars refer to the exception as
"5 U.S.C. § 553(b) (3) (A)." See, e.g., CNI, 818 F.2d at 945; Elizabeth Williams, .That Consti-
tutes "Interpretative Rule" of Agency so as to Exempt Such Action From Notice Requirement of Admin-
istrative Procedure Act (5 § 553(B)(3)(A)), 126 A.L.R. FED. 347, 347 (1995). Most
authorities, however, refer to the exception as falling within 5 U.S.C. § 553(b) (A). See, e.g.,
Thomas v. New York, 802 F.2d 1443, 1447 (D.C. Cir. 1986); Michael Asitnow, Nonlegislative
Rulemaking and Regulatory Reform, 1985 DUKE L.J. 381, 381 n.5 (1985); Daniel A. Kracov &
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The following sections explain in more detail the procedures for
rulemaking, and how agencies may avoid those procedures through
the § 553(b) (A) exception.
A. The Rulemaking Process
Congress has three choices when establishing how agencies pro-
duce legislative rules: 26 (1) to employ the "informal rulemaking" pro-
cess of § 553 of the APA; (2) to use the "formal rulemaking" process
of sections 553, 556 and 557 of the APA; or (3) to employ unique
rulemaking procedures described in the organic statute itself. 27 The
majority of the time, Congress instructs the agency to employ the in-
formal rulemaking process."
The key elements of informal rulemaking—also known as "no-
tice-and-comment"—are that before issuing a legislative rule, an
agency must notify the public of the proposed rule, accept commen-
tary on the proposal and respond to that commentary." Because of
Robert P. Brady, Food and Drug Administration Advisory Opinions and Guidance Documents After
Community Nutrition Institute v. bung, 48 FOOD & DRUG L.J. 47, 47 n.1 (1993).
Other rules exempted from § 553 rulemaking requirements include rules relat-
ing to the military, foreign affairs, agency management, agency personnel, public property,
or when there is good cause for an agency to avoid rulentaldng procedures. See 5 U.S.C.
§ 553(a), (b) (B). This Note will not discuss these other exceptions.
"See 5 U.S.C. §§ 553, 556-557; MASHAW ET AL., supra note 9, at 459.
"See 5 U.S.C. §§ 553, 556-557; 11.IASHAW ET AL., supra note 9, at 459.
28 See 5 U.S.C. §§ 553, 556-557; DAVIS & PIERCE, supra note 9, at 288; MASHAW ET AL.,
supra note 9, at 459; Andrew F. Popper, Administrative Law in the 21st Century, 49 ADMIN. L.
REV. 187, 191 (1997).
"See 5 U.S.C. § 553. See generally DAVIS & PIERCE, supra note 9, at 287-375; Richard J.
Pierce, Jr., Rulemaking and the Administrative Procedure Act, 32 Tulsa L.J. 185, 185-201
(1996). To execute informal rulemaking, an agency must undergo numerous actions. See 5
U.S.C. § 553; PIERCE ET AL., supra note 11, at 321. First, the agency must publish a notice of
proposed rulemaking in the government's official publication, the Federal Register. See 5
U.S.C. § 553(b); Federal Register Act, 44 U.S.C. §§ 15011511 (1994); DeBratin v. Meiss-
ner, 958 F. Stipp. 227, 228 (E.D.. Pa. 1997); OFFICE OF THE FEDERAL REGISTER, NATIONAL
ARCHIVES AND RECORDS ADMINISTRATION, THE FEDERAL REGISTER: WHAT IT IS AND HOW
TO Use IT 3-4 ( Jim Wickliffe & Ernie Sowada eds., rev. 1992). The notice of proposed
rulemaking includes the actual terms or the substance of the proposed rule and the legal
authority behind it. See 5 U.S.C. 553(b); DAVIS & PIERCE, supra note 9, at 298-99. Private
parties may submit commentary to the agency. See 5 U.S.C. § 553(c); DAVIS & PIERCE, supra
note 9, at 299-300. The agency considers the commentary then publishes a final rule in
the Federal Register. See Freedom of Information Act of 1966, 5 U.S.C. § 552(a) (1) (D)
(1994); 5 U.S.C. § 553(c); OFFICE OF THE FEDERAL REGISTER, supra, at 4; PIERCE ET AL.,
supra note 11, at 321; see also Wagner Electric Corp. v. Volpe, 466 F.2d 1013, 1016, 1019-20
(3d Cir. 1072) (noting that the final rule must resemble the proposed rule enough so that
public had opportunity for meaningful comment). When the agency publishes the final
rule, the agency must address the significant commentary in a "concise general statement"
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the provisions for public participation, informal rulemaking generally
is time-consuming and arduous for agencies."
Even more extensive and elaborate than informal rulemaking is
formal rulemaking which, resembling a trial, includes live testimony
and cross-examination. 31 Unique rulemaking procedures vary, but
tend to be less formal than formal rulemakings and more formal than
informal rulemakings. 32 If Congress adopts a statute creating an
agency but does not specify whether the agency has the authority to
create rules, the presumption is that the agency has the authority to
promulgate rules and that it may do so through the informal § 553
process." If an organic statute empowers an agency to promulgate
rules, but does not clearly describe through which process, the default
presumption is to employ the § 553 informal process. 54 Whether an
organic statute prescribes informal, formal or unique rulemaking
procedures, the APA provides for an exception from such proce-
dures."
B. The Section 553(b) (A) Exception
Section 553(b) (A) of the APA carves out an important exception
to the ruletnaking procedures." An agency need not follow the pre-
scribed rulemaking process to create "interpretative rules, general
statements of policy, or rules of agency organization, procedure, or
of the rule's basis and purpose. See 5 U.S.C. § 553(c); Reytblatt v. United States Nuclear
Regulatory Comm'n, 105 F.3d 715, 722 (D.C. Cir. 1997); South Carolina ex rd. Tindal V.
Block, 717 F.2d 874, 886 (4th Cir. 1983); PPG Indus., Inc. v. Costle, 630 F.2d 462, 466 (6th
Cir. 1980); see generally DAVIS & PIERCE, supra note 9, at 309-20. The duration between
publishing a notice of proposed rulemaking and issuing the final rule ranges, but can last
a year or more. See OFFICE OF THE FEDERAL REGISTER, supra, at 7. This procedure exists to
ensure the public has an opportunity to participate in agency action. See, e.g., Chrysler
Corp. v. Brown, 441 U.S. 281, 316 (1979); Tindal, 717 F.2d at 885; American Bus. Ass'n v.
United States, 627 F.2d 525, 528 (D.C. Cir. 1980); PIERCE ET AL., supra note 11, at 321; U.S.
DEP'T OF JUSTICE, supra note 3, at 9.
soSee 5 U.S.C. § 553; Anthony, Intoprewtive Rules, supra note 21, at 1319; Thomas, supra
note 23, at 134.
31 See 5 U.S.C. §§ 553, 556-557; MAsHAw ET AL., supra note 9, at 459-60.
32SCCMASHAW ET AL., supra note 9, at 459; PIERCE ET AL., supra note 11, at 330-31.
"See, e.g., National Petroleum, 482 F.2d at 673-98 (presuming agencies have rulemaking
authority); MASHAW ET AL., supra note 9, at 459.
mSee Automotive Parts & Accessories Ass'n v. Boyd, 407 F.2d 330, 337 (noting that
when the organic statute is ambiguous, it is appropriate to presume the agency may em-
ploy § 553 informal rulemaking rather than §§ 553, 556-557 formal process); MASHAW ET
AL., supra note 9, at 459.
"Sce 5 U.S.C. § 553(b) (A).
"See id.
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practice."37 The APA fails to define these terms, and the courts have
had difficulty interpreting the exception. 38 In general, courts have
held that interpretative rules elucidate statutory law, general state-
ments of policy •announce potential agency actions and rules of
agency organization pertain to the internal operations of an agency. 39
These definitions, however, are vague, and courts often struggle with
how to apply these definitions to the rules that agencies create. This
lack of clarity has caused considerable confusion over what agency
rules fall within the § 553(b) (A) exception, and the consequent legal
effects of those rules.4°
Attempting to discern the meaning of the § 553(b) (A) exception,
the United States Supreme Court has relied on the explanations
found in the 1947 Attorney General's Manual (the "Manual"). 41 'The
Court gives considerable weight to the Manual because the Justice
Department was heavily involved in creating the APA. 42 The Manual
provides that interpretative rules explain statutes and that general
statements of policy pronounce future agency actions. 43 The Attorney
General contrasted interpretative rules and general statements of pol-
37 1d.
"See, e.g., 5 U.S.C. §§ 551, 553; Chrysler, 441 U.S. at 302 ii.31; Federal Labor Relations
Auth. v. United States Dep't of Navy, 966 F.2d 747, 762 /1.14 (3d Cir. 1992) [hereinafter
"FLRA"]; CiV/, 818 F.3d at 946; Pacific Gas & Elec. Co. v. Federal Power Comin'n, 506 F.2d
33, 37-38 (D.C. Cir. 1974).
"See, e.g., 5 U.S.C. § 553(b) (A); Thomas, 802 F.2d at 1446; Batterton v. Marshall, 648
F.2d 694, 702 n.34 (D.C. Cir. 1980); Guardian Fed. Say. & Loan Ass'n v. Federal Say. &
Loan Ins. Corp., 589 F.2d 658, 666 (D.C. Cir. 1978); U.S. DEP'T OF JUSTICE, supra note 3, at
30 n.3.
40See, e.g., 5 U.S.C. §§ 551, 553; American Milling Congress v. Mine Safety & Health
Admin., 995 F.2d 1106, 1109 (D.C. Cir. 1993); FLRA, 966 F.2d at 762 n.14; CNI, 818 F.3d at
946; Kracov & Brady, supra note 25, at 49-50; Marianna E. Beets, Good Guidance Improves
Regulations: a Case Study with the FDA, 15 No. 4 ALA NEWS 23, 23-24 (1996).
41 See, e.g., Shalala v. Guernsey Mein'l Hosp., 514 U.S. 87, 99 (1995); Chrysler, 441 U.S. at
302 IL.31.
42See, e.g., Chrysler, 441 U.S. at 302 n.31; Vermont Yankee Nuclear Power Corp. v. Natu-
ral Resources Defense Council Inc., 435 U.S. 519, 546 (1978); DAVIS & PIERCE, supra note
9, at 13-14; MASHAW ET AL., supra note 9, at 9.
43See U.S. DEP'T OF JUSTICE, supra note 3, at 30 11.3. According to the Attorney Gen-
eral's Manual, interpretative rules are "rules or statements issued by an agency to advise
the public of the agency's construction of the statutes and rules which it administers" and
general statements of policy are "statements issued by an agency to advise the public pro-
spectively of the manner in which the agency proposes to exercise a discretionary power."
Id. The Manual, however, provides almost no information regarding rules of agency or-
ganization. See id.
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icy with "substantive rules," another term for legislative rules." Legis-
lative rules may be substantive, meaning they may have binding,
significant and immediate effects on the rights and obligations of the
public. 45 Legislative rules bear the full force of law, and therefore, the
public and the government must abide by them as if they were stat-
utes.'" Nonlegislative rules, on the other hand, lack the binding effect
of law and may not create obligations, convey rights or cause
significant effects.47 Agencies must perform notice-and-comment pro-
cedure prior to issuing a legislative rule, but producing a nonlegisla-
tive rule requires no such process.'" Congress created this exception
to provide agencies with some degree of flexibility.'"
"See id. at 22-23, 30 11.3; see also Anthony, Interpretative Rules, supra note 21, at 1321
11.37 (lamenting how courts and agencies use the term "substantive rules" in place of leg-
islative rules").
45See Chrysler; 441 U.S. at 301-02; Perales v. Sullivan, 948 F.2d 1348, 1354 (2d Cir.
1991); Brock v. Cathedral Bluffs Shale Oil Co., 796 F.2t1 533, 537 (D.C. Cir. 1986); Marshall,
648 F.2d at 701-02; Pacific Gas, 506 F.2d at 38.
46See Chrysler, 441 U.S. at 301-02; Cathedral Bluffs, 796 F.2d at 537; sec also Pierce, supra
note 29, at 186 (stating: legislative rules have effects that are functionally indistin-
guishable front those of statutes").
41See, e.g., Chrysler, 441 U.S, at 301-02, 315-16; Batterton v. Francis, 432 U.S, 416, 425
n.9 (1977); Perales, 948 F.2d at 1354; Cathedral Bluffs, 796 F.2d at 536-38; Marshall, 648 F.2d
at 701-02; Guardian Federal, 589 F.2d at 666; Pacific Gas, 506 F.2d at 38.
48See 5 U.S.C. § 553.
49See, e.g., Chrysler, 441 U.S. at 316. One caveat: the requirements for notice-and-
comment and the nonlegislative rule exception only applies to rules, See, e.g., Lincoln v.
Vigil, 508 U.S. 182, 198 (1993); Citizens to Preserve Overton Park, Inc. v. Volpe, 401 U.S.
402, 414 (1971). According to the APA, a "rule" is "the whole or part of an agency state-
ment of general or particular applicability and future effect designed to implement, inter-
pret, or prescribe law or policy or describing the organization, procedure or practice re-
quirements of an agency ...." 5 U.S.C. § 551(4). Other agency activities, such as
expenditures of funds or investigations, are not rules, so agencies need not perform any
procedure before implementing them. See, e.g., Overton Path, 401 U.S. at 414; Environ-
mental Defense Fund, Inc. v. Costle, 636 F.2d 1229, 1254-56 (D.C. Cir. 1980). For example,
in 1993, in Lincoln u Vigil, the Supreme Court held that the Indian Health Service could
discontinue a benefits program without following notice-and-comment procedure. See 508
U.S. at 195-99. The court explained that whether or not the decision to cease the alloca-
tion of funds to Native Americans was a rule was irrelevant to the holding. See id. at 196-97.
The court reasoned that the agency action could have been a funding decision within
agency discretion and not subject to rulemaking procedures. See id. at 197-98. Likewise,
the decision could have been a rule of agency organization or a general statement of pol-
icy falling within agency discretion, so even if it had been a "rule," informal rulemaking
process was unnecessary. See id. at 195-99; Overton Part 401 U.S. at 414.
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C. Purposes Behind the Administrative Procedure Act and the Section
553(b)(A) Exception
Congress created the rulemaking procedures of § 553 to strike a
compromise between administrative efficiency and public participa-
tion." The central restraint of the APA's rulemaking procedures is to
ensure that agencies hear public opinion before acting. 51 Thus, the
APA makes agencies more accountable to the public and discourages
arbitrary agency action.52
Several Supreme Court and Circuit Court of Appeals opinions
have expounded upon the purposes behind the APA, the rulemaking
procedures and the nonlegislative rule exception.53 The Supreme
Court stated in 1974 in Morton v. Ruiz, that by forcing agencies to be
well-informed and to incorporate. public opinion, Congress strove to
prevent agencies from acting arbitrarily or unfairly when it passed the
APA.54
 In the 1978 case,. Guardian Federal Savings and Loan Association
v. Federal Savings and Loan Insurance Corporation, the United States
Court of Appeals for the District of Columbia Circuit expanded upon
the APA's requirements of public participation.55 Requiring public
participation, the court asserted, assures that when an agency creates
a legislative rule the agency will have before it the facts and informa-
tion relevant to a particular problem, as well as suggestions for alter-
native solutions 5s
 The court concluded that public rulemaking pro-
cedures increase the likelihood of administrative responsiveness to
the needs and concerns of those affected by agency rules. 57 In addi-
tion, the court reasoned that because Congress has provided a proce-
dure for public participation, the public tends to acquiesce to the
final agency action even when objections to substance remain. 58 Sim-
ply by knowing that there are procedures providing people with a fair
"See Chrysler; 441 U.S. at 316; Guardian Federal, 589 F.2d at 662; U.S. DEPT OF JUSTICE,
supra note 3, at 9.
51 See 5 U.S.C. §§ 553. 556-557; U.S. DEPT OF JUSTICE, supra note 3, at 26.
"See, e.g., Chrysler, 441 U.S. at 316; New Jersey Dep't of Envtl. Protection v. United
States Envtl. Protection Agency, 626 F.2d 1038, 1045 (D.C. Cir. 1980) [hereinafter
1.4.113EP"1; U.S. DEFT OF JUSTICE, supra note 3, at 26.
"See, e.g., Chrysler; 441 U.S. at 316; Guardian Federal, 589 F.2d at 663.
54See Morton v. Ruiz, 415 U.S. 199, 232 (1974).
"See Guardian Federal, 589 F.2d at 662.
56See id.
57See id.
"See id.
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chance to participate in administrative decision making, the public
will be more likely to accept the fitial outcome without dispute. 59
Notice-and-continent requirements serve beneficial purposes, but
courts have recognized that it is very useful when agencies avoid no-
tice-and-comment by properly employing the § 553(b) (A) excep-
tion.° Nonlegislative rules are useful because, without burdening
agencies with notice-and-comment process, they allow agencies to act
more efficiently.61 For instance, agencies are able to quickly produce
rules of agency organization to better manage and streamline their
operations.62 In addition, the nonlegislative rule exception encour-
ages agencies to disseminate information to the public. 65 By publish-
ing information, agencies aid the long-range planning of regulated
private entities' and promote uniformity in areas of national con-
cern." When an agency makes suggestions, private parties have an
incentive to follow the agency's advice because the agencies tend to
be well-informed in their fields of expertise. 65 Moreover, by issuing
nonlegislative rules, an agency notifies the public that the agency
eventually may develop that nonlegislative rule into an actual legisla-
tive rule.°
"See id. In 1979, in Chrysler Corp. v. Brown, the Supreme Court wrote that "bin enact-
ing the APA, Congress made a judgment that notions of fairness and informed administra-
tive decisionmaking require that agency decisions be made only after affording interested
persons notice and an opportunity to comment," 441 U.S. at 316.
6°See, e.g., Marshall, 648 F.2d at 702 n.34; Pacific Gas, 506 F.2d at 38; see also Ashnow, su-
pra note 25, at 385-88 (defending utility of interpretative rules and policy statements);
Lars Noah, The FDA's New Policy on Guidelines: Having Your Cake and Eating it Too, 47 CATH.
U. L. REV. 113, 122-25 (1997) (noting that nonlegislative rules benefit public and agency
by providing consistency); Beem, supra note 40, at 23 (asserting pharmaceutical industry
depends on nonlegislative rules); Joel E. Hoffman, Public Participation and Binding Effect in
the Promulgation of Nonlegislative Rules: Current Developments at FDA, ADM IN. 84 REG. L. NEWS,
Spring 1997, at 1 (stating that the practical importance of nonlegislative rules is "undeni-
able").
6ISee Marshall, 648 F.2d at 7021134; Pacific Gas, 506 F.2d at 38.
62See Chrysler; 441 U.S. at 31011.41; Marshall, 648 F.2d at 70211.34.
635ee Pacific Gas, 506 F.2(1 at 38.
6a See
65See Dole v. United Steelworkers of Am., 494 U.S. 26, 33 (1990) (noting that agencies
develop expertise in their fields); Bowen v. Massachusetts, 487 U.S. 879, 908 (1988) (not-
ing that agencies deserve discretionary power because of their technical expertise).
66See Pacific Gas, 506 F.2d at 38 (stating that nonlegislative rules assist long-term plan-
ning of regulated parties); Been', supra note 40, at 23 (noting that industries rely on non-
legislative rules to plan ahead); Hoffman, supra note 60, at 1 (same).
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The problem with the nonlegislative rule exception is that agen-
cies may sometimes take advantage of the confusion surrounding it. 67
To avoid the rulemaking process, agencies sometimes create rules and
label them as nonlegislative rules. Agencies then treat those rules as
if they were legislative rules with binding legal force.° In essence,
agencies attempt to create legislative rules disguised as nonlegislative
rules." RecOgnizing a misapplication of the exception can be
difficult; the courts have found that nonlegislative and legislative rules
are not easily distinguishable."
D. Distinguishing Between Nonlegislative and Legislative Rules
Agencies often issue rules without following the § 553 process, yet
treat those rules as if they bore the full force of the law." Courts fre-
quently examine disputed rules and determine whether they are non-
legislative, as the agencies claim, or whether they are legislative and,
oSee, e.g., GUI, 818 F.2d at 945-47 (finding that the agency tried to mislabel substantive
rule as interpretative); American Bus., 627 F.2d at 531-32 (same); Reliant° Intl Ltd. v FDA,
678 F. Stipp. 410, 415-16 (E.D.N.Y. 1988) (same); Robert A. Anthony, "We11, Nut Want the
Permit, Don't You?" Agency Efforts to Make Nonlegislative Docu ments Bind the Public, 44 ADMIN.
L. REV. 31, 31 (1992) [hereinafter Well, You Mud the Permit] (arguing that agencies misuse
§ 553(b) (A) exception to create rules to bind the public).
"See Anthony, Interpretative Rules, supra note 21, at 1320. The term "nonlegislative
rules" is used in this Note as an inclusive term meaning not only Interpretative rules, gen-
eral statements of policy, and rules of agency organization, procedure, or practice," but
also "advisory opinions," "guidance documents," "opinion letters, policy statements, pro-
gram policy letters, Dear Colleague letters, regulatory guidance letters, guidelines, staff
instructions, manuals, questions-and-answers, bulletins, advisory circulars, models, en-
forcement policies, action levels, press releases" and other terms employed by federal
agencies for those rules created without rulentaking procedures. See, e.g., Advisory Opin-
ions, 21 C.F.R. § 10.85 (1998) (employing the term "advisory opinions" for the FDA);
Good Guidance Practices, 62 Fed. Reg. 8961, 8967 (1997) (employing the term "guidance
documents" for the FDA); Anthony, Interpretative Rules, supra note 21, at 1320 (mentioning
other designations). The Court of Appeals for the District of Columbia Circuit states it has
"lump[ed]" together the various statements for the purposes of legal analysis. See Syncon
127 F.3d at 93-94.
69 See, e.g., GAIL 818 F.2d at 945; Anthony, Mt, You Want the Permit, supra note 67, at 31-
33.
 70Sec, e.g., CV/, 818 F.2d at 946-47; Anthony, 1Pll, You Want the Permit, supra note 67, at
31-33. In defense of federal agencies, they often provide for public participation when
unnecessary. SeeAshnow, supra note 25, at 381 11.5.
71 See, e.g., GNI, 818 F.2d at 946. The distinction between legislative rules and nonlegis-
lative rules has been described as "tenuous," "enshrouded in considerable smog" and
"fuzzy." Id. (quoting Chisholm v. FCC, 538 F.2d 349, 393 (D.C. Cir. 1976); Noel v. Chap-
man, 508 F.2d 1023, 1030 (2d Cir. 1975); Pacific Gas, 506 F.2d at 37).
72See, e.g., Chrysler, 441 U.S. at 315; CM, 818 F.2d at 945, 948-49; American Bus., 627 F.2d
at 526, 531-32.
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therefore, subject to the informal rulemaking process." If a court
finds that an agency created a rule that is substantive in nature with-
out following the rulemaking process, the court will strike it down as
invalid.74 The courts have ruled that § 553's exceptions must he nar-
rowly construed and should not be used as "escape clauses" for agen-
cies trying to avoid notice-and-comment procedures." The line be-
tween nonlegislative and legislative rules, however, is often unclear."
1. Factors Distinguishing Nonlegislative from Legislative Rules
To distinguish whether a rule is nonlegislative or legislative,
courts consider whether the rule is "substantive" in nature. 77 If a rule
has substantive effects, it should have been promulgated as a legisla-
tive rule, and therefore, the agency should have performed notice-
and-comment to create it." The courts have examined the following
factors:
• Nonlegislative rules do not create law, while legislative rules may
impose or remove legal rights and obligations or produce other
significant effects on private parties."
• If evidence shows an agency intended for a rule to have substan-
tive effects or to legally bind the public, then it is probably a legis-
lative rule."
"See, e.g., Chrysler, 441 U.S. at 315; CM, 818 F.2d at 945, 948-49; American Bus., 627 F.2d
at 526, 531-32; Cooper v. Glickman, 50 F. Stipp. 2d 489, 502-03 (M.D.N.C. 1999).
74See, e.g., CAT/, 818 F.2d at 946-49 (invalidating Food and Drug Administration's "ac-
tion levels" because produced without notice-and-comment yet applied as taw); American
Bus., 627 F.2d at 531-34 (invalidating Interstate Continerce Commission "pronouncement"
because produced without notice-and-comment yet applied as law); Texaco v. Federal
Power Conmen, 412 F.2d 740, 744 (10th Cir. 1969) (invalidating Federal Power Commis-
sion "order" because produced without notice•and-comment yet applied as law).
75 See Alcaraz v. Block, 746 F.2d 593, 612 (9th Cir. 1984) (quoting American Fed'n of
Gov't Employees v. Block, 655 F.2d 1153, 1156 (D.C. Cir. 1981)); NJDEP, 626 F.2d at 1045-
46.
76See, e.g., Sync°, 127 F.3d at 93; CNI, 818 F.2d at 946.
"See, e.g., Chrysler, 441. U.S. at 301 -02.
78 See, e.g., id.
"See id. at 315-16; Perales, 948 F.2d at 1354; Linoz v. Heckler, 800 F.2d 871, 877 (9th
Cir. 1986); Alcaraz, 746 F.2d at 613; Marshall, 648 F.2d at 701-02.
805ee Hudson, 192 F.3d at 1034-35; Fertilizer Inst. v. United States Euvtl. Protection
Agency, 935 F.2d 1303, 1307-08 (D.C. Cir. 1991); Jerri's Ceramic Arts, Inc. v. Consumer
Prod. Safety Comin'n, 874 F.2d 205, 208 (4th Cir. 1989); General Motors Corp. v. Ruckel-
shaus, 742 F.2d 1561, 1565 (D.C. Cir. 1984); Levesque v. Block, 723 F.2d 175. 182-83 (1st
Cir. 1983).
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• Nonlegislative rules leave agency decisionmakers free to exercise
discretion, while legislative rules constrain agency discretion. 81
• Nonlegislative rules employ tentative language, such as "may,"
while legislative rules use mandatory language, such as "will."82
• Agencies should publish legislative rules in the Federal Register,
whereas agencies need not publish nonlegislative rules. 83
• An agency's contention that a rule is nonlegislative shall carry
some weight, but will not be dispositive in a court's determina-
tion whether or not the rule should have been subjected to no-
tice-and-comment rulemaking. 84
81 ,See, e.g., CNI, 818 F.2d at 946; American Bus., 627 F.2d at 529; Guardian Federal, 589
F.2d at 666.
82See, e.g., Cathedral Bluffs, 796 F.2d at 536-38 (citing Guardian Federal, 589 F.2d at 666);
American Bus., 627 E2d at 530; cf. Syncm; 127 F.3d at 95 (rule stating radiopharmaceuticals
"should" be regulated found to be substantive).
83See 5 U.S.C. § 552(a) (1) (D). In 1935, Congress passed the Federal Register Act,
which established the Federal Register as the government's official publication in which
offices of the government may disseminate information. See 44 U.S.C. §§ 1501-1511;
OFFICE OF THE FEDERAL REGISTER, supra note 29, at 1. Publication in the Federal Register
provides official notice of a document's existence and its contents, establishes the text as a
true copy of the original document and authenticates evidence for trial. See OFFICE OF THE
FEDERAL REGISTER, supra note 29, at 1. Each federal working day, the Office of the Federal
Register publishes the Federal Register, providing a uniform system for federal agencies and
the President to notify the public. See id. at 28. Since 1935, Congress has passed other stat-
utes imposing additional obligations on agencies to publish certain statements in the Fed-
eral Register. See id. at 113-15. According to the Freedom of Information Act, federal agen-
cies must publish in the Federal Register:
rules of procedure, ... substantive rules of general applicability adopted as
authorized by law, and statements of general policy or interpretations of gen-
eral applicability formulated and adopted by the agency.... Except to the ex-
tent that a person has actual and timely notice of the terms thereof, a person
may not in any manner be required to resort to, or be adversely affected by, a
matter required to be published in the Federal Register and not so published.
5 U.S.C. § 552(a).
For a rule to be legislative and have substantive effects, it should be published in the
Federal Register. See, e.g., id.; Cathedral Bluffs, 796 F.2d at 538-39. The converse, however, is
not true; if an agency publishes a rule in the Federal Register, that does not necessarily make
the rule legislative. See 5 U.S.C. § 552(a); Cathedral Bluffs, 796 F.2d at 538-39. Agencies
publish many, but not all, nonlegislative rules in the Federal Register. See, e.g., 5 U.S.C.
§ 552(a); Cathedral Bluffs, 796 F.2d at 538-39. Often, agencies publish certain information
only in internal agency materials. See, e.g., Ruiz, 415 U.S. at 204-05. Courts have held that
such information should not have general applicability and usually relates to internal poli-
cies. See, e.g., id. at 235 (noting that the Bureau of Indian Affairs conceded "real legislative
rule[s]" should be published in Federal Register); Cathedral Bluffs, 796 F.2d at 538-39 (noting
that failure to publish in Federal Registeriudicates rule was not meant to bind).
81See, e.g., Mejia-Ruiz v. INS, 51 F.3d 358,365 (2d Cir. 1995); Phillips Petroleum Co. v.
Johnson, 22 F.3d 616,619 (5th Cir. 1994); CM, 818 F.2d at 946; Cathedral Bluffs, 796 F.2d at
537-38; General Motors, 742 F.2d at 1565.
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• Interpretative rules interpret law while legislative rules create
law."
• General statements of policy operate prospectively and speak to
future contingencies, but legislative rules have immediate hn-
pacts. 86
• Rules of agency organization apply only to internal agency
machinations."
The United States Court of Appeals for the District of Columbia
Circuit considered several of these factors in 1987, in Community Nutri-
tion Institute v. Young, where the court held that certain rules which
the FDA had labeled as nonlegislative were actually substantive, and
thus should have been adopted as legislative rules. 88 The court found
the rules to be substantive because they imposed immediate legal ob-
ligations on food producers, they constrained agency discretion and
the FDA had referred to them as having the force of law." The Com-
munity Nutrition Institute ("CNI"), a public interest group, and other
public interest organizations, brought action against the Commis-
sioner of the FDA for granting "action levels" the force and effect of
law, even though the FDA produced them without conducting notice-
and-comment process." The FDA had been initiating enforcement
proceedings against food producers if their goods exhibited levels of
aflatoxins—unavoidable contaminants found in foods such as corn—
"See, e.g., Chrysler, 441 U.S. at 302 n.31, 315-16 (noting that interpretative rules inform
the public how an agency interprets a statute or how it administers its substantive rules and
that interpretative rules do not create binding law); Alcaraz, 746 F.2d at 613 (noting that
interpretative rules are essentially hortatory and instructional and they are used more for
discretionary fine-tuning than for general law making); Pickus v. United States Bd. of Pa-
role, 507 F.2d 1107, 1113 (D.C. 1974) (noting that interpretative rules interpret stat-
utes while substantive rules create procedures expected to be followed by agency person-
nel and the public).
88 Compare, e.g., American Bus., 627 F.2d at 531-32 (finding agency pronouncement im-
mediately altered restrictions for trade between United States and Canada), and Bellarno,
678 F. Stipp. at 411, 416 (holding interpretative rule invalid because it provided for auto-
matic detention of merchandise), with Pacific Gas, 506 F.2d at 41-43 (holding rule assign-
ing who receives allotments of natural gas during possible national shortages to be valid
interpretative rule because tentative and prospective).
87 See Chrysler, 441 U.S. at 310 n.41; Marshall, 648 17.2d at 702 n.34.
88See CNI, 818 F.2c1 at 945-49. The Court of Appeals for the District of Columbia Cir-
cuit hears the majority of cases involving federal agencies, so the court is regarded as hav-
ing developed a level of expertise for administrative law. See Stone v. INS, 514 U.S. 386, 404
(1995); Vermont Yankee, 435 U.S. at 535 n.14.
"See CNI, 818 F.2d at 945-49.
"See id. at 945.
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greater than the action levels.91 Concerned that the action levels were
too low and failed to adequately protect public health, the CNI con-
tended that the action levels should haVe been adopted only after fol-
lowing notice-and-comment procedures. 92 The FDA argued the action
levels fell within the nonlegislative rule exception of § 553(b) (A)."
The court reasoned that the rule establishing the action levels
used mandatory language and created immediate and binding ef-
fects. 94 Specifically, the rules declared that if a food product met an
action level, the food "will be deemed" to be contaminated 45
 Also, the
court found it compelling that the FDA had occasionally intimated
that action levels established binding norms. 98 The FDA would not
initiate enforcement proceedings against food producers that had
amounts of contamination less than the action levels. 97 Thus, the
court held that the action levels constrained agency discretion. 98
 Also,
the court found that the rules were substantive because the FDA re-
quired food producers to seek exemptions to the action levels. 99 The
court found that if private parties must obtain exemptions to circum-
vent an agency's rules, then the agency intends for those rules to be
substantive.m Therefore, the court held that the action levels were
substantive and should have been produced only after notice-and-
comment, and thus were invalid.m
91 See id.
92See id. at 945, 949. •
"See id. at 945.
9d See CV/, 818 F.2d at 947.
"See id.
96See id. at 947-48.
"See id. at 948; Ashutosh Bhagwat, Three-Branch Monte, 72 NOTRE DAME L. REV. 157,
165-66 (1996).
"See CNI, 818 F.2d at 948.
"See id. at 947-49.
i"See id.
mSee id. at 945-49. As a contrasting example, in 1974, in Pacific Gas e.o' Electric Co. u
Federal Power Commission, the United States Court of Appeals for the District of Columbia
Circuit upheld a general statement of policy as a valid nonlegislative rule because it pro-
spectively addressed possible situations, lacked significant effects and created no binding
law. See 506 F.2d at 35, 42-43, 45. In Pacific Gas, the Federal Power Commission issued a
statement describing how it would allocate natural gas in case of a national shortage. See id.
at 35-36. Several consumers of natural gas, particularly electric generating companies,
challenged the statement by arguing it was substantive and should have been generated
through § 553 process. See id. at 36. The court explained that although legislative rules
establish standards of conduct with the force of law, general statements of policy merely
announce what the agency seeks to establish as policy. See id. at 38. The court concluded
that the policy statement was merely an announcement of the agency's future plans, so it
did not require notice-and-comment process. See id. at 41, 45. The court noted that the
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2. Some Courts Still Use "Substantial Impact" as a Factor
Some courts—including the Fourth and Fifth Circuits—use "sub-
stantial impact" as a factor to determine whether a rule should have
been promulgated following notice-and-comment procedure. 102 If a
rule has a substantial impact on private parties, then it is a legislative
rule.03 The courts do not provide extensive explanation as to what
qualifies as "substantial impact," but the case law suggests that if a rule
imposes upon private parties dramatic economic changes, the rule
has a substantial impact. 144 Since the Supreme Court's decision in
Vermont Yankee Nuclear Power Corp. v. Natural Resources Defense Council in
1978, however, the test has fallen into disfavor and most courts ignore
it. 105
3. The "Public Good" Should Not Be a Factor
Litigants have argued that public policy should enter into courts'
decision-making, but courts generally rule only on process and do not
critical distinction between general statements of policy and legislative rules is that policy
statements have no binding effect on future administrative proceedings while legislative
rules create new law which courts must follow. See id. at 38. Because the statement of policy
was prospective and created no law, the court held it was a nonlegislative rule and, there-
fore, valid. See id. at 42-43,45.
"See, e.g., Phillips Petroleum, 22 F.3d at 620-21; Alexandria v. Helms, 728 F.2d 643,647-
48 (4th Cir. 1984); Pickus, 507 F.2d at 1112-13.
"See, e.g., Alexandria, 728 F.2d at 647-48; Pickus, 507 F.2d at 1112.
"See, e.g., Phillips Petroleum, 22 F.3d at 620-21. For example, in 1994, in Phillips Petro-
leum Co. v. Johnson, the United States Court of Appeals for the Fifth Circuit held that the
Department of Interior ("D01") should have subjected a disputed ''procedure paper" to
notice and comment process because it had a substantial impact on the natural gas indus-
try. See 22 F.3d at 621. The procedure paper established new criteria for valuing natural gas
liquid products. See id. at 618. The DOI argued the procedure paper was merely the
agency's interpretation of a legislative rule. See id. at 619-20. Because the new rule in-
structed the DOI to change its valuation method from considering the range of various
types of natural gas prices to considering only "spot" market prices, the court reasoned
that the rule "dramatically" affected the royalty values of all oil and gas leases. See id. at
620-21. Despite how the agency labeled the rule, the court struck it clown because it was
created without process and it substantially impacted private parties. See id, at 619,621.
tossee,
 e.g., Alcaraz, 746 F.2d at 613; Levesque, 723 F.2d at 182; Elizabeth Williams, supra
note 25, § 8 (1995). In Vermont Yankee, the Court did not explicitly undo the substantial
impact test, but the Court undermined the test to such a degree that it is no longer dis-
positive. See Vermont Yankee, 435 U.S. at 524,543-45. The Supreme Court held that courts
cannot order agencies to conduct more process than already prescribed by statute or sub-
stantive rule. See id. at 543-44. The Court found unpersuasive plaintiffs' argument that
because the subject matter of the case—construction of a nuclear power plant—was an
"[i]ssue() of Great Public Import," the court should order the agency to conduct addi-
tional procedure before issuing a rule. See id. at 54a-,15.
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incorporate the "public good" into their analyses. 1°6 Most courts rule
that they have only the authority to review whether agencies followed
prescribed procedures and whether agencies violated the law, but not
whether agencies have formulated flawed opinions.]°7 An agency is,
ideally, composed of experts in the particular field over which it regu-
lates, and a judge is, ideally, an expert in the field of law. 108 In princi-
ple, judges do not substitute agency thinking with their own opin-
ions. 109 Instead, courts generally review agency process, not agency
judgment. 11° Hence, courts tend to analyze the agency's procedure
rather than the real world policy effects of agency judgment. 111 As a
result, the duty to provide for the public good remains with Congress
and the agencies. 112
II. THE LEGAL EFFECTS OF RULES
Depending on whether a rule. is adopted with or without notice-
and-comment process, the rule will have different legal effects. 113 Leg-
islative rules produced after notice-and-comment procedures consti-
tute substantive law and legally bind both agencies and private parties
ill future legal and administrative proceedings. 114 Conversely, non-
legislative rules generally may not have binding legal effects. 1 l3 Non-
legislative rules, however, sometimes have practical legal effects." 6
106 See id. at 549; Alcaraz, 746 F.2d at 610.
07SeeChnion, United States, Inc. v. Natural Resources Defense Council, 467 U.S. 837,
865-66 (1984); I iTinont Yankee, 435 U.S. at 524, 543-50.
108 See Chevron, 467 U.S. at 865-66.
109 See id.
"nee id.; Vermont Yankee, 435 U.S. at 549; Alcaraz, 746 F.2d at 610.
1" See Chevron, 467 U.S. at 865-66; Vermont Yankee, 435 U.S. at 549; Alcaraz, 746 F.2d at
610.
"2See Chevron, 467 U.S. at 864-65; Vermont Yankee, 435 U.S. at 549; Alcaraz, 746 F.2d at
610.
n3See Shalala v. Guernsey Metal Hosp., 514 U.S. 87, 99 (1995); Chrysler Corp. v.
Brown, 441 U.S. 281, 295, 315-16 (1979).
u4See Bureau of Alcohol, Tobacco & Firearms v. Federal Labor Relations Auth., 464
U.S. 89, 98 n.8 (1983); Chrysler, 441 U.S. at 295, Brock v. Cathedral Bluffs Shale Oil Co.,
796 F.2d 533, 537 (D.C. Cir. 1986); Pacific Gas & Elec. Co. v. Federal Power Conine'', 506
F.2d 33, 38 (D.C. Cir. 1974).
u5See, e.g., Guernsey, 514 U.S at 99; Chrysler, 441 U.S. at 315-16; Linoz v. Heckler, 800
F.2d 871, 877 (9th Cir. 1986).
u6SeeAnthony, Interpretative Rules, supra note 21, at 1328-29.
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A. Nonlegislative Rules Generally Cannot Have Binding Legal Effects
Rules created without process—interpretative rules, general
statements of policy, rules of agency organization and other nonlegis-
lative rules—generally cannot have legally binding effects. 117 In ad-
ministrative and judicial proceedings, nonlegislative rules are not
treated as law, but as influential agency thought that may factor into a
proceeding's outcome. 118
According to the courts, nonlegislative rules cannot be the deci-
sive factor in a court proceeding or enforcement action." 9 For exam-
ple, in 1986, in Thomas v. New York, the Court of Appeals for the Dis-
trict of Columbia Circuit held that a letter written by the
Administrator of the Environmental Protection Agency could not
have binding legal effects because it had not been subjected to notice-
and-comment process. 120 Several eastern states—including New York,
national environmental groups, American citizens owning property in
Canada and a Congressman brought suit against Lee Thomas, Admin-
istrator of the EPA under President Reagan in the early 1980s, for not
revising certain air pollution standards. 121 Prior to Thomas taking the
helm of the EPA, Douglas Costle had been the EPA's Administrator
under President Carter.122 Days before Reagan took office, Costle
wrote a letter to then Secretary of State Edmund Muskie indicating
that based on the findings of an official joint American-Canadian
commission, he believed pollution emitted by the United States was
responsible for causing acid rain in Canada. 123 According to the 1977
amendments to the Clean Air Act, if the Administrator of the EPA de-
termines that American air pollution is causing significant harm in
Canada, the EPA must order the states causing the acid rain to reduce
loSee, e.g., Hudson v. Federal Aviation Admin., 192 F.3d 1031,1034-35 (D.C. Cir. 1999);
Guernsey, 514 U.S. at 99; Chrysler, 441 U.S. at 315-16.
u8See, e.g., Smith v. Midland Brake, Inc., 180 F.3d 1154, 1165-67 (10th Cir. 1999).
119See, e.g., Guernsey, 514 U.S. at 99; Chrysler; 441 U.S. at 315-16.
120.See Thomas v. New York, 802 F.2d 1443, 1445-47 (D.C. Cir. 1986).
121 See id. at 1445-46.
122See id. at 1444-45. For a brief description of Thomas, see Robert L. Brubaker & Ju-
dith L. French-Berry, Is a Rule by Any Other Name Still a Rule?• Case Answew Under the Clean
Air Act, 18 N. Ky. L. Rev. 271, 273-76 (1991). For a more thorough history and analysis,
see Carol Garland, Acid Rain over the United States and Canada: The D.C. Circuit Fails to Pro-
vide Shelter under Section 115 of the Clean Air Act 1Vhile State Action Provides a Temporary Um-
brella, 16 B.C. ENVTL. Arm'. L. REV. 1, 18-29 (1988).
123See Thomas, 802 F.2d at 1445; Jeffrey L. Roelofs, United States-Canada Air Quality
Agreement: A Framework for Addressing Transboundary Air Pollution Problems, 26 CORNELL INT'L
L.J. 421, 436-37 (1993).
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air pollution.12" Then, those states would be obligated to intensify the
regulation of the private parties contributing to air pollution within
the states' jurisdictions.'" The new Administrator, Thomas, chose to
ignore the letter. 126 Intent on reducing acid rain in Canada, the plain-
tiffs brought suit, arguing that the letter obliged the EPA to force the
generating states to.revise their air pollution controls.'"
The court found that the letter constituted a rule within the
meaning of the APA and that it had not been created as a result of any
rulemaking process. 128 The court reasoned that the rule did not fall
within any of the § 553(b) (A) exceptions because it affected individ-
ual rights and obligations by causing the states to heighten their regu-
lations, which would result in the termination or restriction of nu-
merous utilities and manufacturers.'" Because the EPA had not
followed the notice-and-comment process to create the rule, the EPA
was not required to constrain its discretion by abiding by the letter." 0
The holding in Thomas evidences the principle that nonlegislative
rules cannot have binding legal effects.'" Reality, however, may differ
from this principle."2
B. Agencies May Try to Apply Nonlegislative Rules as Law Against Private
Parties
When agencies treat a nonlegislative rule as law, those rules will
have the practical effect of binding law because people tend to acqui-
esce to that which the government informs them constitutes the
law.'" Most members of the public assume all agency rules constitute
legitimate law, so they simply conform to all rules.' By treating non-
124See Thomas, 802 F.2d at 1446.
125See id. at 1445.
126Sce id.
121 See id. at 1445-46; Shawn M. Rosso, Acid Rain: The Use of Diplomacy, Policy and the
Courts to Solve a Trans boundary Pollution Problem, 8 J. NAT. RESOURCES & ENS-rt.. L. 421, 431-
32 (1992-1993).
128See Thomas, 802 F.2d at 1446-47; Steve Russell, Continent, Potential Fallout From the
National Acid Precipitation Assessment Program. 6 Bl'U J. Pus. L. 423, 430 (1992). For the
definition of a rule, see 5 U.S.C. § 551(4).
129See Thomas, 802 F.2d at 1447.
1 "See id. at 1447-0.
"'See, e.g., Chrysler 441 U.S. at 301-03, 315-16; Batterton v. Marshall, 648 F.2d 694,
701-02 (L).C. Cir. 1980); Pacific Gas, 506 F.2d. at 38-39.
132See.ekiithony, Interpretative Rules, supra 'rote 21, at 1328-30.
1"See id.
Is4SeeAshnow, supra note 25, at 384.
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legislative rules as law, agencies can convince the public into following
nonlegislative rules.' 35
Occasionally, agencies rely upon nonlegislative rules for en-
fcircement actions.'" For example, in 1989 in United States v. Picciotto,
the Court of Appeals for the District of Columbia reversed a convic-
tion based upon a nonlegislative rule because, by virtue of prescribing
unlawful conduct, the rule imposed binding obligations on the pub-
lic.'" In 1981, Concepcion Picciotto began a six year, twenty-four-
hour-per-day protest against nuclear war across the street from the
White House in LaFayette Park. 138 In 1988 the Park Service issued an
"additional condition" without performing any notice-and-comment
procedures.'" The additional condition prohibited the storage of
property in LaFayette Park beyond that which is reasonably necessary
to stage a twenty-four hour protest. 10 A Park Service police officer
arrested Picciotto for violating the additional condition.m The
United States District Court for the District of Columbia found her
guilty and gave her a ten-day suspended prison sentence and six
months unsupervised probation. 142 The Court of Appeals reversed the
conviction, holding that the additional condition was substantive be-
cause it imposed obligations enforceable by criminal penalty, even
though the Park Service had created it without notice-and-
comment. 143 Although Picciotto won her appeal, this case demon-
strates how agencies may create rules without notice-and-comment
and treat them as binding law. 144 Besides initiating or threatening en-
forcement actions based on nonlegislative rules, agencies often rely
on them to grant or deny applications and permits.' 45 Similarly, fed-
"5.SeeAnthony, Interpretative Rules, supra note 21, at 1328-31.
130.See United States v. Picciotto, 875 F.2d 345, 346 (D.C. Cir. 1989); Jerri's Ceramic
Arts, Inc. v. Consumer Prod. Safety Comm'n, 874 F.2d 205, 206-07 (4th Cir. 1989); An-
thony, Interpretative Rules, supra note 21, at 1333.
137 See 875 F.2d at 348-49.
138 .See id. at 346.
139See id.
14osee id,
' 4 'See id.
142 See Picciotto, 875 E2d at. 346.
145 See id. at 346-49.
144 See id.
145See, e.g., United States v Apex Oil Co., 132 F.3c1 1287, 1288-89, 1291 (9th Cir. 1997)
(upholding dismissal of oil tanker captains indicted by the Coast Guard for causing oil
pollution according to the terms of a nonlegislative rule); American Bus. Ass'it v. United
States, 627 F.2d 525, 527, 531-34 (D.C. Cir. 1980) (holding nonlegislative rules regarding
applications to transport goods to Canada to be substantive and therefore invalid); An-
thony, Interpretative Rules, supra note 21, at 1333, 1340.
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eral agencies can utilize nonlegislative rules to influence programs
administered by the states. 148
As the trial court did in Picciotto, courts sometimes agree with the
agencies and treat nonlegislative rules as binding law. 147 For instance,
in 1993, in United States v. American National Red Cross, the District
Court for the District of Columbia issued an injunction against the
Red Cross, as part of a settlement, ordering the Red Cross to conform
with all of the FDA's nonlegislative rules regarding blood. 148 Con-
cerned with the integrity of the blood supply, the FDA passed numer-
ous legislative and nonlegislative rules regarding how blood was to be
handled. 149
 Finding that the Red Cross had failed to meet the stan-
dards imposed by the FDA, the court specifically differentiated be-
tween the FDA's legislative rules and nonlegislative rules, and ordered
the Red Cross to abide by both. 150 Therefore, rules created without
notice-and-comment became binding law for the Red Cross. 151
1 ' See, e.g., Levesque v. Block, 723 F.2d 175, 177-78 (1st Cir. 1983) (involving "interim
rules," issued by the Secretary of Agriculture, which reduced expenditures to New Hamp-
shire Food Stamp program); Marshall, 648 F.2d at 696-99 (involving -Balance of State pro-
cedure," issued by the Department of Labor, which reduced expenditures to Maryland
unemployinent program). See also Anthony, Interpretative Rules, supra note 21, at 1353.
147
 See, e.g„ Picciotto, 875 F.2d at 349 (reversing trial court's conviction based on non-
legislative rule); United States v. American Nat'l Red Cross, 1993 WL 186094, at *1—*2
(D.D.C. 1993) (issuing injunction ordering company to abide by numerous nonlegislative
rules).
148See 1993 WL 186094, *1—*2; see generally Dept. of Justice, Injunction Gives FDA Broad
Power over Red Cross, DEP'T OF JUSTICE ALERT, May 1993, at 13-15 [hereinafter Injunction].
Created by an act of Congress, the Red Cross is a private corporation that supplies blood to
health care facilities. See Red Cross, 1993 WL 186094, at I.
us see, e.g.,- 21 C.F.R. §§ 210-11, 600-80 (1998); Red Cross, 1993 WL 186094, at *1—*2.
Both the FDA and the Red Cross have been targets in lawsuits by families of those who
contracted AIDS from blood transfusions. See, e.g., Doe v. American Nat'l Red Cross, 112
F.3d 1048, 1048-50 (9th Ch-. 1997).
150 .See Red Cross, 1993 WL 186094, at *2. The opinion states:
Within the time frames specified in this Decree, [the Red Cross] shall take
steps necessary to ensure compliance with: (a) the provisions set forth in this
Decree; (b) the [Food, Drug and Cosmetics Act], the [Public Health Service
Act], and all applicable regulations (hereafter, collectively, the law"); and (0
(the Red Cross] standard operating procedures, including, but not limited to, Blood
Services Directives ("BSDs"), Blood Service Letters ("BSLs"), regional and local stan-
dard operating procedures, and any other instruments (hereafter, collectively, "SOPs').
Id. (emphasis added).
Throughout the injunction, the court ordered the Red Cross to follow the SOPs. See
id. at *1—*14; see also Injunction, supra note 148, at 13 (noting injunction's provisions "de-
tailed," "broad" and "numerous").
151 See Red Cross, 1993 WL 186094, at *2.
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C. Analysis of the Legal Effects of Nonlegislative Rules
The situation in Red Cross must be avoided because it robs the
public of the opportunity to offer input on nonlegislative rules. 152 Be-
cause the Red Cross, the FDA and the court agreed to this settlement,
the FDA's nonlegislative rules regarding blood bind the Red Cross,
even though the rules create new law, impose legal obligations, have
immediate effects, are not necessarily published in the Federal Register
and may have significant effects on the public.'" Moreover, the public
lost the opportunity to participate in the creation of laws that will af-
fect many people, including patients in need of blood transfusions. 154
When courts allow nonlegislative rules to have substantive effects
on the public, they undermine the foundation underlying the APA
and the notice-and-comment procedures therein. 155 Nonlegislative
rules should not impose obligations or immediate effects on the pub-
lic, and courts and agencies should strive to avoid using them in such
a manner. Too often, nonlegislative rules have a practical binding le-
gal effect because people do not realize those rules are not binding.
The parties affected by the rules choose to acquiesce to the rules
rather than attract agency attention, they lack the resources to chal-
lenge the rules, or they have already fought the rule in court and have
given up on the appeals process. 158
Agency personnel and the public should be able to use nonlegis-
lative rules for guidance, but not as binding law. 157 This would allow
agency personnel to deviate freely from nonlegislative rules, therefore
producing the downside of diminished uniformity between agency
actions. 158 Accordingly, for matters on which an agency wishes to act
152See id. at *1—*2.
155See id.; see also, e.g., Morton v. Ruiz, 415 U.S. 199,235 (1974) (noting that rules with
binding effects should be published); Marshall, 648 F.2d at 701-02 (noting that nonlegisla-
tive rules do not impOSe obligations); Alcaraz v. Block, 746 F.2d 593,613 (9th Cir. 1984)
(interpretative rules do not create new laW); American Bus., 627 F.2d at 531-32 (noting that
interpretative rules may not have immediate effects).
15 See Red Cross, 1993 WL 186094, at *1—*2.
155See, e.g., 5 U.S.C. § 553 ; Weyerhaeuser Co. v. Costle, 590 F.2d 1011,1027-28 (D.C.
Cir. 1978) (stating that the APA infuses the administrative process with "openness, expla-
nation and participatory democracy"); Red Cross, 1993 WI. 186094, at *1—*2.
156See Anthony, Interpretative Rules, supra note 21, at 1327-32; Asin ►ow, supra note 25, at
384.
157See, e.g., Alcaraz, 746 F.2d at 613 (noting that interpretative rules are essentially hor-
tatory and instructional and they are used more for discretionary fine-tuning than for
general law snaking).
158 Cf. Noah, supra note 60, at 120-27 (suggesting that nonlegislative rules should bind
because that would foster agency consistency).
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consistently, it would not be able to rely on nonlegislative rules.
Rather, the agency should follow the APA procedures for creating
binding, uniform rules: legislative rules created after notice-and-
comment process. 159
Either Congress, the courts or the agencies themselves should
create law clarifying that nonlegislative rules cannot have binding ef-
fects. 16° For example, the FDA recently promulgated a set of rules to
better exercise the § 553 (b) (A) exception. 161 On their surface, the
FDA's new rules attempt to elucidate how the agency will create non-
legislative rules and to pronounce that nonlegislative rules lack bind-
ing legal effect. 162
 The next Part analyzes the FDA's new rules, as well
as an act proposed by the Senate to reform agency regulation in gen-
era1. 163
III. THE FUTURE OF NONLEGISLATIVE RULES
Many members of Congress have argued that federal agencies
create too many regulations and cost the American public and the
United States government too much money. 164 Many have clamored
for a reform of agencies that would dramatically restrain agency
authority to create legislative rules. 165 Possibly as a response to Con-
gress's plans for broad reforms and the confusion surrounding non-
legislative rules, the FDA has taken steps to clarify how it creates and
applies its nonlegislative rules. 166
159See 5 U.S.C. § 553.
160 .5ee, e.g., Guardian Fed. Say. & Loan Ass'n v. Federal Say. & Loan Ins. Corp., 589 F.2d
658,666 (D.C. Cir. 1978).
161 See Good Guidance Practices, 62 Fed. Reg. 8961,8967-71 (1997) (to be codified at
21 C.F.R. pt. 10).
162See id.
163 SCe infra, notes 164-293 and accompanying text.
164See, e.g., COMMITTEE ON GOVERNMENTAL AFFAIRS, THE REGULATORY IMPROVEMENT
ACT or 1999, S. REP. No. 106-110, at 5-6 (1999) (language identical to CommirrEE ON
GOVERNMENTAL AFFAIRS, THE REGULATORY IMPROVEMENT ACT OF 1998, S. REP. No. 105-
188, at 5-6 (1998)).
165See, e.g., S. REP. No. 106-110, at 1-4 (language identical to S. REP. No. 105-188, at
1-4).
• 166See id.; see also Hoffman, supra note 60, at 10-11 (noting that the FDA created Good .
Guidance Practices because the agency had become potential target for Congress to enact
administrative reform).
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A. The Food and Drug Administration's Good Guidance Policies
In February of 1997, the FDA published a set of guidelines enti-
tled Good Guidance Practices ("GGPs") in the Federal Registen 167 The
GGPs set forth the Agency's policies and procedures for the develop-
ment, issuance and use of "guidance documents"—the FDA's term for
nonlegislative rules.' 68 The FDA has asserted that the purposes of
guidance documents are to clarify statutes or substantive rules and to
implement the Agency's congressional mandate in an "effective, fair,
and consistent manner." 169
Among the revisions listed in the. GGPs, the FDA provided for
clearer nomenclature and greater public input.'" The GGPs revised
the appropriate terminology for guidance documents by requiring all
of them to include the label "guidance."'" The term "guidance
documents" includes and excludes numerous categories of docu-
ments.'" As well, guidance documents must identify to whom they
apply.'" According to the GGPs, the FDA will publish a list of all of its
guidance documents in the Federal Register 174 Furthermore, the FDA
loSee Good Guidance Practices, 62 Fed. Reg. at 8967-71.
1t8See id. The FDA previously requested suggestions on how best to improve its proce-
dures addressing interpretative rules. See Request for Comments Regarding the FDA's De-
velopment and Use of Guidance Documents, 61 Fed. Reg. 9181, 9181 (1996).
169 See Good Guidance Practices, 62 Fed. Reg. at 8967.
u0See id. at 8967-71.
InSee id. at 8969.
02See id. at 8967. "Guidance documents" include:
documents prepared for FDA staff, applicants/sponsors, and the public that:
(1) Relate to the processing, content, and evaluation/approval of submis-
sions; (2) relate to the design, production, manufacturing, and testing of
regulated products; (3) describe the agency's policy and regulatory approach
to an issue; or (4) establish inspection and enforcement policies and proce-
dures. "Guidance documents" do not include documents relating to internal
FDA procedures, agency reports, general information documents provided to
consumers, speeches, journal articles and editorials, media interviews, press
materials, warning letters, or other communications directed to individual
persoris or firms.
Id.
175See id. at 8969.
1745ce Good Guidance Practices, 62 Fed. Reg. at 8969. For example, the FDA published
lists of guidance documents in the Federal Register at: Update of Guidance Documents at
the Food and Drug Administration, 64 Fed. Reg. 42,382, 42,382-91 (1999); Annual Com-
prehensive List of Guidance Documents at the Food and Drug Administration, 64 Fed.
Reg. 31,228, 31,228-80 (1999); Quarterly List of Guidance Documents at the Food and
Drug Administration, 64 Fed. Reg. 888, 888-903 (1999); Quarterly List of Guidance
Documents at the Food and Drug Administration, 63 Fed. Reg. 36,413, 36.413-24 (1998);
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will update existing guidance documents to include these standards as
the Agency revises them. 175
In addition, the GGPs establish a mechanism to include public
participation in the development of guidance documents. 176 The
GGPs rank guidance documents into two levelslevel 1 and level l-
and establish procedures for public input for both.'" Prior to prom-
ulgating level 1 guidance documents, the FDA will solicit public input
by posting a draft of the document on the FDA's World Wide Web
home page. 178
 Then, the FDA will review all comments before prom-
ulgating the final guidance document. 179
 For level 2 guidance docu-
ments, the FDA will provide an opportunity for the public to com-
ment after the FDA issues and implements them. 180
Furthermore, the GGPs stipulate that guidance documents are
not binding on the public or the FDA. 181 The proposed GGPs instruct
FDA personnel that Ib]ecause guidance documents are not binding,
mandatory words such as `shall,"must,"require' and 'requirement'
are inappropriate . ."182 Correspondingly, the GGPs declare that
Comprehensive List of Current Guidance Documents at the Food and Drug Administra-
tion, 63 Fed. Reg. 9795, 9795-9843 (1998).
176 See Good Guidance Practices, 62 Fed. Reg. at 8969.
176See id. at 8968-69.
177See id. at 8968. For an example of a level 1 guidance, see the guidance for industry
entitled Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products (visited Oct.
1, 1999) Chttp://www.fda.gov/cder/guidance/2836dfilitm > (notice of availability pub-
lished at 64 Fed. Reg. 29,657, 29,657 (1999)). For an example of a level 2 guidance, see the
compliance guide entitled Evaluation and Processing Post Donation Information Reports (visited
Oct. 1, 1999) <http://www.fcla.gov/ora/compliance_ref/cpg/cpgbio/cpg230-140,htna >
(notice of availability published at 64 Fed. Reg. 44,740, 44,740-41 (1999)). Note that the
FDA also publishes guidances without classifying them as either level 1 or 2. See Interna-
tional Conference on Harmonisation; Guidance on Specifications: Test Procedures and
Acceptance Criteria for Biotechnological/Biological Products, 64 Fed. Reg. 44,928, 44,929
(1999).
"8.See Good Guidance Practices, 62 Fed. Reg. at 8968 (mentioning FDA WWW home
page, at <http://www. fda.gov›).
1795ee id. The GGPs provide three exceptions, allowing the FDA to issue level 1 guid-
ance without prior public input if:
(1) there are public health reasons for immediate implementation; (2) there
is a new statutory requirement, executive order, or court order that requires
immediate implementation and guidance is needed to help effect such im-
plementation; or (3) the guidance is presenting a less burdensome policy that
is consistent with public health.
Id.
utosce id,
181 See id. at 8967, 8969.
182 See Good Guidance Practices, 62 Fed. Reg. at 8969. The entire provision states:
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lgluidance documents do not themselves establish legally enforce-
able rights or responsibilities and are not legally binding on the pub-
lic or the agency. "183 FDA guidance documents will state:
This guidance document represents the agency's current
thinking on * * *. It does not create or confer any rights for
or on any person and does not operate to bind FDA or the
public. An alternative approach may be used if such ap-
proach satisfies the requirements of the applicable statute,
regulation, or both.184
Another part of the GGPs reads, in pertinent part: "decisionmakers
will take steps to ensure that their staff do not deviate from the guid-
ance document without appropriate justification and appropriate su-
pervisory concurrence." 185
B. Analysis of the Good Guidance Policies
The FDA's proposed GGPs represent a worthy first step because
they attempt to abrogate some of the confusion surrounding non-
legislative rules. 186 The GGPs ultimately fail, however, because they
include contradictory notions and they do not address all nonlegisla-
tive rules. 187 Nevertheless, some of the GGPs' provisions serve prudent
public policy. 188
Absence of Mandatory Language. Because guidance documents are not bind-
ing, mandatory words such as "shall," "must," "require" and "requirement"
are inappropriate unless they are being used to describe or discuss a statutory
or regulatory requirement. Before a new guidance is issued, it should be re-
viewed to ensure that mandatory language has not been used.
Id.
1831d. at 8967. When the FDA published the GGPs in the Federal Registei; the agency
stated that the GGPs were, ironically enough, still nonbinding guidance documents, pend-
ing the amendment of FDA's regulations. See id at 8961. The FDA intimated that it
planned to update its current legislative rules, which state that an FDA interpretative rule
"obligates the agency to follow it." See Advisory Opinions, 21 C.F.R. § 10.85 (1998); Good
Guidance Practices, 62 Fed. Reg. at 8961. In its commentary on the GGPs, the FDA as-
serted that it would begin adhering to the GGPs although it has not yet fully implemented
them. See Good Guidance Practices, 62 Fed. Reg. at 8961.
184Id. at 8969.
18.5 /d. at 8967.
186See id. at 8961-71; Hoffman, supra note 60, at 11 (noting that commentators ap-
plauded FDA's effort, but highly criticized GGPs).
1815ee Good Guidance Practices, 62 Fed. Reg. at 8961-71; infra notes 196-236 and ac-
companying text.
119 ,See Good Guidance Practices, 62 Fed. Reg. at 8969.
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1. The Benefits of the Good Guidance Practices
The GGPs provide some improvements to how the FDA ap-
proaches nonlegislative rules. For example, requiring all guidelines to
specify to whom they apply can only enhance understanding among
the public and the Agency.189 Additionally, printing a list of all non-
legislative rules in the Federal Register contributes to better awareness
of the FDA's rules.I99
The provisions providing for public participation in the creation
of guidance documents serve the purposes behind the APA. 191 The
process for creating level 1 guidance documents resembles informal
rulemaking because the FDA will accept commentary and respond to
it.I92
 This procedure seems beneficial because it fosters public partici-
pation, which makes the Agency better aware and the public better
represented.198
 This arrangement raises the question, however, if the
agency is going to accept commentary prior to implementing a rule,
why not simply employ informal notice-and-comment rulemaking as
defined in the APAP 94 Perhaps the FDA wishes to have more informa-
tion when it promulgates guidelines lacking the binding force of law,
thereby reserving agency discretion. 198 Regardless, the two-tier system
is not completely successful. Like the rest of the GGPs, it presents po-
tential problems.
2. Problems with the Good Guidance Practices
The two-tier system may contribute to the fog already engulfing
nonlegislative rules. 196 Now, rather than legislative rules versus non-
legislative rules, people must contend with legislative rules, level 1
guidance and level 2 guidance. Also, the provision for level 2 guid-
ance offers no improvement to the status quo. Because the agency will
not consider public comment prior to issuing a level 2 guidance, level
2 guidance is the same as a nonlegislative rule. Essentially, level 2
189 See id.
19°See id.
191 See id. at 8968-69.
192See id. at 8968; Nancy K. Plant, Prescription Drug Promotion on the Internet: Tool for the
Inquisitive or Trap for the Unwary?, 42 Sr. LOUIS U. L.J. 89, 93 n.26 (1998).
193See Good Guidance Practices, 62 Fed. Reg. at 8968.
194 See id.
1955ee id.; see also, e.g., Community Nutrition lust. v. Young, 818 F.2d 943, 948 (D.C. Cir.
1987) (noting that nonlegislative rules cannot restrain agency discretion).
196 .See Good Guidance Practices, 62 Fed. Reg. at 8968.
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guidance documents are everyday nonlegislative rules, while level 1
documents purport to be pseudo-legislative rules. 197
One problem that could arise from this arrangement is that the
FDA could publish notice of a proposed level 1 guidance document,
accept commentary and publish the rule. 198 Later, the FDA may treat
the document as if it were binding law by arguing the Agency con-
ducted notice-and-comment while creating the document, so it has
met the requirements of § 553. 1 " The FDA should not take this path,
because a private party potentially could overlook or disregard a pro-
posed level 1 guidance document, while that same party would have
taken more seriously a proposal for an actual legislative rule.289 Still,
by encouraging public participation, the procedure for creating level
1 guidances will probably accomplish more good than
Furthermore, the two-level system could confuse the process by
which the FDA repeals rules. To repeal a legislative rule, an agency
must create a second legislative rule.202 To repeal a nonlegislative
rule, an agency need only issue another nonlegislative rule. 2" Be-
cause both level 1 and level 2 guidance documents are nonlegislative
rules, the FDA could use either level to amend or repeal a guidance
within another level. For example, the FDA could create a level 1
guidance document after the public has an opportunity to participate,
then later amend or repeal that document with a level 2 guidance
document without engaging in notice-and-comment. 204 Such a situa-
tion would mislead the public and negate the accountability inherent
in the process to create level 1 guidance. The FDA should not have
bothered to introduce the two-tier system because it adds to the com-
plexity of nonlegislative rules.
The main problem with the GGPs, however, is that they create
contradictory presumptions. 2" The GGPs state that the FDA must
197 See id.; Plant, supra note 192, at 93 n.26.
108 See Good Guidance Practices, 62 Fed. Reg. at 8968.
199 See id.
21"See id.
"'See id.; sec, e.g., Guardian Fed. Say. & Loan Ass'n v. Federal Say. & Loan Ins. Corp.,
589 F.2d 658, 662 (D.C. Cir. 1978) (noting that public participation improves agency
ruletnaking).
2°2See American Mining Congress v. Mine Safety & Health Admin., 995 F.2d 1106,
1109-10 (D.C. Cir. 1993).
203See Chevron, United States, Inc. v. Natural Resources Defense Council, 467 U.S. 837,
865-66 (1984); see also Hudson is Federal Aviation Admin., 192 F.3c1 1031, 1035 (D.C. Cir.
1999) (upholding policy statement that negated prior policy statement).
204See Good Guidance Practices, 62 Fed. Reg. at 8968.
2"See id.
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avoid including words such as "shall" and "must" in guidance docu-
ments and that the FDA's guidelines will not "operate to bind FDA or
the public."206 Elsewhere, the GGPs contradict these provisions by de-
claring that FDA personnel must follow guidance documents unless
there is "appropriate justification and appropriate supervisory con-
currence."207 The no-mandatory-language and do-not-operate-to-bind
provisions establish a presumptiOn that FDA personnel are not bound
by guidance documents, but the appropriate-justification-and-
concurrence provision establishes a presumption that agency person-
nel are bound by guidance documents. 208 This inconsistency will only
prove to exacerbate the schizophrenia already surrounding the
§ 553(b) (A) exception. Agency personnel will be unsure how to act
and private entities will be uncertain whether nonlegislative rules may
bind agency personnel and whether the rules may have indirect
obligatory effects on them.209
Aimed at improving administrative consistency, the appropriate-
justification-and-concurrence provision initially may appear pru-
dent."° The provision puts the public on notice that the FDA usually
will do as it says. The appropriate-justification-and-concurrence provi-
sion establishes a presumption that the FDA must follow its guide-
lines. It also provides two vague exceptions, allowing staff members to
deviate from them if they have "appropriate justification" or "appro-
priate supervisory concurrence."211 The GGPs, however, fail to define
either exception. 212
The meaning of "appropriate justification" is completely un-
clear.213
 The other half of the exception, that employees can only de-
viate from guidelines with "appropriate supervisory concurrence," is
also vague, but probably more usefu1. 214 While the phrase "appropri-
ate supervisory concurrence" is horribly imprecise, it seems to create
a procedural step.215
 The GGPs suggest that before an FDA employee
may abridge a guidance document, the employee must obtain permis-
sion from a superior. The GGPs, unfortunately, do not explain further
206See id. at 8967, 8969.
07
 See id. at 8967.
2" See id. at 8967, 8969.
209See Good Guidance Practices, 62 Fed. Reg. at 8967, 8969.
210&e id. at 8967.
R"See id.
212See id.
213See id.
214See Good Guidance Practices, 62 Fed. Reg. at 8967.
ruse,
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the exception.236 Should a low-level FDA employee simply ask his su-
pervisor for permission? Should .an employee write a formal petition
to the Administrator? Should supervisors obtain permission from
higher-ranking managers before authorizing subordinates to deviate
from guidance documents? The language creates the possibility for an
FDA employee with subordinates to circumvent the spirit of the GGPs.
For example, if a supervisor orders a subordinate to deviate from
guidance documents and simultaneously grants that subordinate the
authority to perform the action—which could arguably amount to
"supervisory concurrence"—the supervisor can ignore nonlegislative
rules.217
The no-mandatory-language and do-not-operate-to-bind provi-
sions, however, help resolve the complexity surrounding nonlegisla-
tive rules. 218 As numerous courts have held, nonlegislative rules
should not include compulsory language and may not create legally
binding standards. 219 By emphasizing this point for agency personnel,
the FDA is wisely serving itself and the public. If both agency employ-
ees and members of the public understand that nonlegislative rules
use tentative language and are not legally binding, less confusion will
exist. All parties concerned will understand that nonlegislative rules
are only tentative guidelines, and that only legislative rules carry the
force of law.
To remedy the contradiction in the GGPs, the FDA should excise
the appropriate-justification-and-concurrence provision and maintain
both the no-mandatory-language and do-not-operate-to-bind provi-
sions.220 Including the appropriate-justification-and-concurrence pro-
uasee id
2 t 7See id.; Hoffman, supra note GO, at 11 (pointing out that commentators have noted
the GGPs pay insufficient attention to ensuring FDA personnel will follow them).
21HSee Good Guidance Practices, 62 Fed. Reg. at 8967, 8969.
219See, e.g., Brock v. Cathedral Bluffs Shale Oil Co., 796 F.2d 533. 536-38 (D.C. Cir.
1986); Good Guidance Practices, 62 Fed. Reg. at 8967, 8969.
=See Good Guidance Practices, 62 Fed. Reg. at 8967, 8969. In a comment written in
1996, the Community Nutrition Institute ("CNI") recommended the FDA specify that its
guidelines have no legal effect in judicial proceedings and that the FDA should not expect
courts to defer to those guidance documents. See David Wirth, Comments of the Commu-
nity Nutrition Institute on FDA's Notice Concerning Development and Use of Guickuice
Documents 4-8 (1996) (on file with author). Following that logic, the CNI also suggested
the FDA should specify in all of its guidance documents that the guidelines do not limit
agency discretion. See id. at 4-8. As the CNI suggested, the FDA would do better to estab-
lish the presumption that the agency may not always follow guidance documents because
they are never legally binding. See id. at 4-8. The CNI also recommended that the GGPs
should specify guidance documents are final agency actions and should explain standards
for judicial review of guidance documei ts. See id.
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vision will only cause more confusion. The purpose behind the provi-
sion seems to be to assure the public that agency personnel will follow
guidance documents.221 Because the appropriate-justification-and-
concurrence provision is so ambiguous, however, FDA personnel
could easily sidestep agency guidelines. 222 Moreover, informing the
public that there is a presumption that agency personnel follow guid-
ance documents would mislead the public, because courts of law will
hold otherwise. 225
The FDA should retain the do-not-operate-to-bind provision, but
it should expand on it.224 The FDA should provide further informa-
tion and explain the ramifications of the provisions. The GGPs should
specify that FDA personnel may not rely on nonlegislative rules to es-
tablish obligations on private parties, initiate enforcement actions or
affect applications.225 Nonlegislative rules are a confusing subject mat-
ter, and the FDA would do well to thoroughly describe to its person-
nel and constituents how to approach them.
One other potential problem is that the GGPs state that guidance
documents include only certain types of agency statements. 226 The
GGPs never actually mention interpretative rules, general statements
of policy, nonlegislative rules or § 553(b) (A). 227 The language of the
GGPs suggests that interpretative rules and policy statements would
fall under the definition of guidance documents, but that is not ex-
plicitly stated. 228 Therefore, it is possible that the FDA could create a
rule without notice-and-comment process and label it as an "interpre-
tative rule," even though that rule creates rights and obligations and
is actually a legislative rule in disguise. 229 If a private party challenges
the validity of the rule and tries to classify it as a guidance document,
which by the FDA's own GGPs cannot operate to bind the public, the
FDA could argue that the rule is an interpretative rule and not a
guidance document. Thus, the GGPs should state that "guidance
documents" also include all agency statements promulgated under
221 .See Good Guidance Practices, 62 Fed. Reg. at 8967.
222See id.
223See, e.g., Cathedral Bluffs, 796 F.2d at 536-38.
224See Good Guidance Practices, 62 Fed. Reg. at 8067, 8969.
225See id.; Anthony, Interpretative Rules, supra note 21, at 1332-55.
226 See Good Guidance Practices, 62 Fed. Reg. at 8967.
22ISee id.
228 See id. at 8967-69.
222 See id. at 8967.
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§ 553 (b) (A) of the APA. 25° That would help reduce the confusion sur-
rounding the exception and guidance documents. 231
Finally, the GGPs fail because by describing the numerous types
of agency statements that do not fall within the term "guidance
documents"—such as internal FDA procedures, agency reports, jour-
nal articles, press releases and speeches—the FDA suggests that such
statements could operate to bind the Agency and the public. 02 The
GGPs state that guidance documents may not operate to bind and
may not include mandatory language, so by excluding these other
categories of statements, the GGPs imply that FDA personnel may
treat them as legally binding. 2" The FDA could circumvent the pur-
poses of the APA by issuing an "agency report"—a document
specifically excluded from the definition of guidance documents—
without taking into account public input, and then treat that report as
binding iaw.234 Again, the FDA has an opportunity to issue a rule in
nonlegislative trappings that could have significant effects on the pub-
lic.235
Thus, the GGPs fail to curtail the abuses and misunderstandings
surrounding the § 553(b) (A) exception. 236 The GGPs, however, suc-
ceed in introducing some worthwhile measures that may help assuage
the nonlegislative rule dilemma. Specifically, explaining that guidance
documents do not operate to bind, specifying to whom guidance
documents apply, requiring the FDA to publish all of its guidance
documents, and providing for more public input in the creation of
leVel 1 guidance are pragmatic provisions. The GGPs, however, apply
to only one agency. To establish greater efficiency and consistency in
the use of nonlegislative rules throughout the federal government,
Congress ought to revise nonlegislative rules for all agencies.
C. The Proposed Regulatory Improvement Act
Senator Carl Levin (D-MI), with Fred Thompson (R-TN) and
numerous other co-sponsors, introduced the Regulatory Improve-
2"See 5 U.S.C. § 553(b) (A); Good Guidance Practices, 62 Fed. Reg. at 8967.
251 See 5 U.S.C. § 553(b) (A); Good Guidance Practices, 62 Fed. Reg. at 8967.
222 See Good Guidance Practices, 62 Fed. Reg. at 8067.
2s3See id. at 8967, 8969.
"4 See id.
235SCe id.
236See 5 U.S.C. § 553(b) (A); Good Guidance Practices, 62 Fed. Reg. at 8967-71.
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meat Act of 1999 ("Act") to the Senate. 257
 In July 1999, the Senate
Committee on Governmental Affairs ("Committee") published a Re-
port on the proposed Act. 238
 In the Report, the Committee noted that
the annual cost of agency regulations is nearly $300 billion and that
there are about sixty federal agencies issuing regulations at a rate of
approximately 4000 per year. 239
 The Committee contended that fed-
eral agencies overly regulate and interfere with individuals, businesses
and local govermnents. 249
 The proposed Act provides that federal
agencies should follow complex procedural requirements before
adopting "major" legislative rules—those that would impose costs of
more than $100 million. 241
 According to the Act, when agencies at-
tempt to adopt major legislative, rules they would have to conduct
thorough cost-benefit analyses at both the proposed and final rule-
making stages.242
 If an agency attempts to create rules affecting
health, safety or the environment, the agency also would have to con-
duct a thorough risk assessment. 243
 Moreover, the Act provides the
237 See The Regulatory Improvement Act of 1999, S. 746, 106th Cong. §§ 601-12, 621-
29, 631-32, 641-44 (1999). In 1997, Senator Levin first introduced the Regulatory Im-
provement Act during the 105th Congress. See S. 981, 105th Cong. (1997). Senator
Thompson was one of the bill's first co-sponsors, and people often refer to the bill as the
Levin-Thompson Regulatory Improvement Act. See John F. Cooney, Regulatory Reform: The
Long and Winding Road, 23 ADMIN. & REG. L. NEWS, Fall 1998, at 1. During 1998, the bill's
title changed to the Regulatory Improvement Act of 1998. See S. 981, 105th Cong. (1998).
For the 106th Congress, Senator Levin reintroduced the bill, virtually unchanged, in 1999
as S. 746, the Regulatory Improvement Act of 1999.
218See COMMITTEE ON GOVERNMENTAL AFFAIRS, THE REGULATORY IMPROVEMENT ACT
OF 1999, S. REP. No. 106-110. In 1998, the Senate Committee on Governmental Affairs
published a report describing the proposed act, then bill S. 981. See CommurrEE ON Gov-
ERNMENTAL AFFAIRS, THE REGULATORY IMPROVEMENT ACT OF 1998, S. REP. No. 105-188.
In 1999, the Senate Committee on Governmental Affairs issued another report—almost
identical to the 1998 report—to accompany the proposed statute. See S. REP. No. 106-110.
239See S. REP. No. 106-110, at 5-6 (language identical to S. REP. No. 105-188, at 5-6).
sosee id
.
•
241 See S. 746. A "major rule" is a rule that:
(A) the agency proposing the rule or the Director [of the Office of Manage-
ment and Budget] reasonably determines is likely to have an annual effect on
the economy of $100,000,000 or more in reasonably quantifiable costs; or
(B) is otherwise designated a major rule by the Director on the ground that
the rule is likely to adversely affect, in a material way, the economy, a sector of
the economy, including small business, productivity, competition, jobs, the
environment, public health or safety, or State, local or tribal governments, or
communities ....
S. 746 § 621(7). For a brief overview of the proposed statute, see generally Cooney, supra
note 237, at 1.
242See S. 746 § 623(b), (c).
243 See id. § 624.
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Office of Management and Budget ("OMB")—an agency mandated to
improve the efficiency of other administrative agencies—with the
authority to conduct oversight review of major rules. 244
The Regulatory Improvement Act states that it does not apply to
rules falling within § 553's exceptions. 245 The Senate Report, however,
states that if a nonlegislative rule "alters or creates rights or obliga-
tions of persons outside the agency," then it must be considered a leg-
islative rule within the meaning of the proposed Act.246 Furthermore,
the Report reads:
the Committee cautions the agencies that any statement of
general applicability that actually alters or creates rights or
obligations of persons outside the agency is included in this
definition. While informal agency guidance is encouraged,
agencies should not attempt to evade the requirements of
this legislation through mischaracterizations of such materi-
als.247
Although the proposed statute itself does not address interpretative
rules, the accompanying Senate Report addresses the potential misuse
of the § 553 (b) (A) exception. 248
D. Analysis of the Proposed Regulatory Improvement Act
The proposed Regulatory Improvement Act says little about non-
legislative rules and the Act's potential effect on them is unclear. 249
The language of the Senate Report attempts to restrain agencies that
may misuse nonlegislative rules by requiring burdensome and time-
consuming cost-benefit analyses and risk assessments for substantive
rules dressed in the trappings of nonlegislative rules. 25° It appears that
244See Office of the Management and Budget Act, 31 U.S.C. §§ 501-22 (1994); S. 746
§ 642.
245SeeS, 746621(10)(A).
2+6S. REP. No. 106-110, at 27 (language identical to S. REP. No. 105-188, at 23).
zusee
248See id.; Daniel Cohen, S. 981, The Regulatory Improvement Act of 1998: The Most Recent
Attempt to Develop a Solution in Search of a Problem, 50 ADMIN. L. REV. 699.705-06 (1998).
249See S. 746 § 621(10); S. REP. No. 106-110, at 26-27 (language identical to S. REP. No.
105-188, at 22-23). For a criticism of the proposed Act, see generally Cohen, supra note
248; Esther Boykin, Poor Proposal on Federal Regulatory Changes, THE TIMES-PICAYUNE, July
19, 1999, at B4. For an argument in support of the bill, see C. Boyden Gray, Regulatory Re-
form: Past and Future, NAT. RESOURCES & ENV'T, Winter 1998, at 158-59; Jeff Stier, Better
Ways to Regulate, J. OF COM.JUly 8, 1998, at 7A.
2()See S. REP. No. 106-110, at 27 (language identical to S. REP. No. 105-188, at 23).
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some members of Congress are well aware that agencies sometimes
use the nonlegislative rule exception to avoid proper rulemaking pro-
cedures.251 The Senate Committee's command to agencies that they
should properly label their rules may discourage agencies from misla-
beling their legislative rules as nonlegislative.252
If Congress passes the Act, however, it is just as likely that agen-
cies may attempt to abuse the nonlegislative rule exception more of-
ten than before. 255 If all major legislative rules must follow more pro-
cess than the already burdensome § 553 procedure, agencies may
attempt to avoid the procedures more often by disguising legislative
rules as nonlegislative.254
 An agency could issue a rule creating costs
of more than $100 million, yet identify it as an interpretative rule or a
general statement of policy.255 Considerable time could pass before
the OMB or an aggrieved private party challenges the rule and de-
mands the agency conduct a cost-benefit analysis.256 The agency would
be taking a risk by mislabeling its rules, in effect daring the OMB or
the public to act. 257 That risk, however, may be worthwhile for agen-
cies. 258
 The proposed Act imposes such huge burdens on agencies
that they will adopt fewer legislative rules than they do now.259 Accord-
ingly, to continue meeting the demands of their congressional man-
dates, agencies may have no choice but to rely more heavily on the
nonlegislative rule exception. 26
The Act specifically states that nonlegislative rules are excluded
from the cost-benefit analysis requireMents, but does not specifically
address those major substantive rules mislabeled as nonlegislative. 261
251 See id.
252See id.
253See id.; see also Anthony, Interpretative Rules, supra note 21, at 1318 (discussing how
agencies inclined to use § 553(b) (A) exception to avoid ruletnaking procedures).
254See S. 746 §§ 621(7), 623-24.
ntSee id. § 621(7); see, e.g., Phillips Petroleum Co. v. Johnson, 22 F.3d 616, 618, 621
(5th Cir. 1994) (noting that the agency placed nonlegislative label on substantive rule
`dramatically" affecting oil and gas royalty values).
256See S. 746 §§ 623, 642.
257See id. § 642; S. REP. No. 106-110, at 27 (language identical to S. REP. No. 105-188,
at 23).
'See S. 746 § 642; S. REP. No. 106-110, at 27 (language identical to S. REP. No. 105-
188, at 23).
255See S. 746 §§ 623-24; S. REP. No. 106-110, at 27 (language identical to S. REP. No.
105-188, at 23); Anthony, Interpretative Rules, supra note 21, at 1319 (noting that some
agencies already view rulemaking procedure as burdensome).
260See S. REP. No. 106-110, at 27 (language identical to S. REP. No. 105-188, at 23).
%1 See S. 746 § 621; S. REP. No. 106-110, at 27 (language identical to S. REP. No. 105-
188, at 23).
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Rather, only in the Report does the Senate assert that nonlegislative
rules with major effects must be subjected to cost-benefit analysis. 262
Were this issue ever to come up in litigation, the court would probably
consider the Senate Report, but it would not be dispositive. 263 A court
could hold that the language of the proposed Act is sacrosanct and
that nonlegislative rules simply cannot be major rules. 264 Of course, if
a rule costs more than $100 million, it probably also has significant
effects or creates legal obligations, and a judge would probably hold
that it must be a legislative rule.265 One way or the other, the small
discrepancy can only contribute to the confusion surrounding
§ 553(b) (A).266 The Committee would be wise to rewrite § 621(10) (A)
of the Act to reflect that substantive rules disguised as nonlegislative
must go through the cost-benefit analysis. 267 Such a revision of the Act
would be more consistent with the original intentions behind the
APA.
The purpose of the APA is to bolster clarity, consistency and pub-
lic participation in federal agencies. 268 If Congress adopts the Act as is,
it would undermine these beneficial aims to the extent that it fails to
ameliorate the confusion surrounding nonlegislative rules.269 Con-
gress should not adopt the Regulatory Improvement Act in its current
form.270 If Congress seeks to implement meaningful regulatory re-
form, Congress ought to revise § 553(b) (A) of the APA now. 271
262 See S. REP. No. 106-110, at 27 (language identical to S. REP. No. 105-188, at 23).
26SSee id.
264 .See S. 746 § 621(10) (A); S. REP. No. 106-110, at 27 (language identical to S. REP.
No. 105-188, at 23).
265 .See S. 746 § 621(7); see, e.g., Thomas v. New York, 802 F.2d 1443,1447 (D.C. Cir.
1986) (implying letter was substantive because its enforcement would cause considerable
economic impact).
266 See 5 U.S.C. § 553(b) (A); S. 746 § 621(10) (A); S. REP. No. 106-110, at 27 (language
identical to S. REP. No. 105-188, at 23).
267 See S. 746 § 621(10) (A); S. REP. No. 106-110, at 27 (language identical to S. REP.
No. 105-188, at 23).
268 .See 5 U.S.C. §§ 553, 556-57; White v. Shalala, 7 F.3d 296,303 (2d Cir. 1993).
269See S. 746 § 621; S. REP. No. 106-110, at 27 (language identical to S. REP. No. 105-
188, at 23).
270See S. 746 § 621. Much debate still encircles the proposed Act, and members of
Congress currently are considering amending the bill. See William A. Niskanen, Legislative
Implications of Reasserting Congressional Authenity over Regulations, 20 CARDOZO L. REV. 939,
943-44 (1999).
271See 5 U.S.C. § 553; S. 746 § 642; S. REP. NO. 106-110, at 27 (language identical to S.
REP. No. 105-188, at 23). Differing from this Note's argument, the American Bar Associa-
tion has voiced its support for the proposed Act because it would increase uniformity be-
tween federal agencies and provide for systemic review of agency rules. See Warren Belmar,
Chair's Message, ADmir 1. & REG. L. NEWS, Spring 1998, at 2. Nevertheless, the proposed Act
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E. Congress or the Agencies Should Revise Nonlegislative Rules
Nonlegislative rules continue to confuse the government and
public alike, and agencies still are able to misuse them to bind the
public.272
 Whether Congress or agencies attempt to remedy the non-
legislative rule problem, they should affect law that would require
federal agencies to: (1) correctly and uniformly label nonlegislative
rules; (2) publish a list of all of their nonlegislative rules in the Federal
Register; (3) avoid using mandatory language in nonlegislative rules;
(4) specify that nonlegislative rules do not legally bind either agencies
or individuals; (5) specify that neither the public nor the government
should rely on nonlegislative rules; and (6) remember to use the full
informal § 553 process when creating rules with substantive effects. 273
The best solution would be for Congress to amend the APA to
better explain the § 553 (b) (A) exception.274 . Courts repeatedly have
lamented that Congress has never defined or revised nonlegislative
rules.275
 According to the Senate Committee on Governmental Af-
fairs, Congress is aware that there is the potential for abuse of
§ 553(b)(A). 276
 The confusion over nonlegislative rules has existed for
more than half a century and calls for a legislative response. 277 Be-
cause Congress is currently considering reforming how administrative
has failed to garner widespread support. See Marc Landy & Kyle D. Dell, The Failure of Risk
Reform Legislation in the 104th Congress, 9 DUKE Errvm. L. & POL'Y F. 113, 131 n.83 (1998).
But see OFFICE OF THE GENERAL COUNSEL, SEC, RECENT LEGISLATIVE DEVELOPMENTS AF-
FECTING THE WORK OF THE SECURITIES AND EXCHANGE COMMISSION 536-37 (1998) (sug-
gesting the bill has considerable support because only two witnesses voiced opposition to it
during a hearing before the Senate Governmental Affairs Committee).
272SeeAnthony, Interpretative Rules, supra note 21, at 1316, 1327-55.
273 .See, e.g., Shalala v. Guernsey Mein'l Hosp., 514 U.S. 87, 99-100 (1995) (noting that
nonlegislative rules lack the force and effect of law); CVI, 818 F.2d at 948 (noting that
nonlegislative rules cannot restrain agency discretion); Cathedral Bluffs, 796 F.2d at 536-38
(noting that nonlegislative rules should only use tentative language); Good Guidance
Practices, 62 Fed. Reg. at 8967-71 (recommending uniform nomenclature, listing all non-
legislative rules, eschewing mandatory language and that nonlegislative rules may not bind
public or agency).
274SeeU.S.C. § 553(b) (A).
275 See, e.g., 5 U.S.C. § 551, 553; Chrysler Corp. v. Brown, 441 U.S. 281, 302 n.31 (1979);
CV/, 818 F.2d at 946; Noel v. Chapman, 508 F.2d 1023, 1029-30 (2d Cir. 1975).
276See S. REP. No. No. 105-188, at 23.
277 See 5 U.S.C. §§ 551, 553; •IASHAW ET AL., supra note 9, at 148. Congress, however,
has made few substantial changes to the APA over its 53-year history. See MASHAW ET AL.,
supra note 9, at 149; Strauss, supra note 15, at 1391-92.
December 1999]	 Nonlegislalative Rules as Binding Law	 191
agencies regulate in general, now is the ideal time to address non-
legislative rules. 278
Congress should create a "Nonlegislative Rule Act," which would
amend and clarify the law surrounding the § 553(b) (A) exception. 279
The courts have held that nonlegislative rules should not employ
mandatory language and that they cannot have binding effects. 289
Agencies, however, are able to manipulate the § 553(b) (A) exception
to impose substantive effects on the public. 281 The best solution to
halt this potential for abuse is for Congress to legislate that all rules
created without notice-and-comment cannot have binding legal ef-
fects on agencies or the public, unless they fall under another of
§ 553's categorical exceptions. 282 Learning from the FDA's GGPs,
Congress should require agencies to publish lists of their nonlegisla-
tive rules in the Federal Register and to refer to those rules with a uni-
form nomenclature. 283 Furthermore, the hypothetical Nonlegislative
Rule Act should require agencies to avoid using compulsory language
in their nonlegislative rules, to specify that nonlegislative rules do not
legally bind either agencies or individuals and to assert that neither
the public nor the government should rely on nonlegislative rules. 284
In addition, Congress statutorily should compel agencies to use full
notice-and-comment process when creating rules with substantive ef-
fects. 285 The courts have ruled that only legislative rules may create
rights or obligations, so agencies should rely only on notice-and-
comment to create binding and consistent rules of law.286
276Sce Cindy Skrzycki, The Regulators: The Costs and Benefits of Cost-Benefit Analysis, THE
WASH. POST, Aug. 6, 1999, at El (stating that the Senate Governmental Affairs Committee
is currently pushing Regulatory Improvement Act toward Senate floor).
279 SCe 5 U.S.C. § 553.
22 °See, e.g., Chrysler, 441 U.S. at 315; Cathedral Bluffs, 796 F.2d at 537-38; American Bus.
Ass'n v. United States, 627 F.2d 525, 529-30 (D.C. Cir. 1980).
20 See, e.g., United States v. American Nat'l Red Cross, 1993 lArl, 186094, *1–*2 (D.D.C.
1993); Anthony, Interpretative Rules, supra note 21, at 1315-16.
222See, e.g., 5 U.S.C. § 553(a), (b) (B); Morton v. Ruiz, 415 U.S. 199, 230-38 (1974)
(holding that rule relating to benefits program, and created without notice-and-comment,
was binding because it was exempted under § 553(a) (2)). The other exceptions—rules
relating to the military, foreign affairs, agency management, public property, public con-
tracts or for emergencies—are more clear than the vague terms "interpretative rules" and
"general statements of policy," so they generate less litigation and controversy. See 5 U.S.C.
§§ 553 (a) ( 1 ), (a) (2), (b)(B).
283See Good Guidance Practices, 62 Fed. Reg. at 8969.
See id. at 8967, 8969.
285See Chrysler, 441 U.S. at 301-02; American Bus., 627 F.2d at 528.
226See Per-ales v. Sullivan, 948 F.2d 1348, 1354 (2d Cir. 1991); Linoz v. Heckler, 800 F.2d
871, 877 (9th Cir. 1986).
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If Congress fails to take this opportunity to amend the Regulatory
Improvement Act's bill, then the agencies should revise how they cre-
ate and apply nonlegislative rules. Although each agency may treat
nonlegislative rules differently, as long as the agencies strive to im-
prove their use of nonlegislative rules, it will benefit the public. Like
the FDA, other agencies should develop their own versions of the
GGPs.287
 The FDA's GGPs are not the best model, however, and other
agencies should attempt to formulate better policies regarding non-
legislative rules.288
 Other agencies would be wise to borrow from the
GGPs the provisions requiring the FDA to publish a list of all of its
guidance documents and to refer to nonlegislative rules with a stan-
dardized nomenclature.289
 The public is always better served when the
government keeps it informed in a lucid and comprehensive man-
ner.2" As argued in Section B of this Part, a better set of GGPs would
not feature contradictory principles, would clarify that nonlegislative
rules do not operate to bind and would not further complicate the
issue by devising a two-tier system.291
 Moreover, agencies should in-
clude in their definitions of nonlegislative rules all rules falling within
the § 553(b) (A) exception. 292
 Other agencies should learn from the
GGPs' mistakes and develop their own more clear and more efficient
policies for nonlegislative rules. 293
CONCLUSION
The federal government is cognizant that agencies sometimes
misuse the § 553(b) (A) exception because of its inherent complexity.
The Food and Drug Administration deserves recognition for attempt-
ing to ameliorate the problem by developing the Good Guidance
Practices. The GGPs, however, fail because they contradict themselves
and leave open avenues for potential agency abuse. While one admin-
istrative agency is confronting the issue, Congress is ignoring it. The
Regulatory Improvement Act of 1999 only briefly touches on the role
of nonlegislative rules. The proposed statute fails to engage the com-
plications surrounding the § 553(b) (A) exception. Moreover, because
"7 See Good Guidance Practices, 62 Fed. Reg. at 8967-71.
5038See id.
289 See id. at 8969.
290See id.; Asimow, supra note 25, at 386 (stating that "nal ecause the public must live
with agency interpretations, it should have the fullest possible access to them.").
29 'See supra notes 196-236 and accompanying text.
292 See Good Guidance Practices, 62 Fed. Reg. at 8967.
2 "See id. at 8967-71.
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of the burdens the Act would impose on administrative agencies, it
could encourage agencies to promulgate nonlegislative rules.
If Congress truly wishes to overhaul the administrative system
with this legislation, Congress should take the opportunity now to
clarify the creation and use of nonlegislatiye rules. Likewise, the FDA
should act soon to revise its GGPs before the agency becomes too en-
trenched with the GGPs' inadequate standards. 294 Specifically, Con-
gress and the agencies should adopt statutes or legislative rules, re-
spectively, ensuring that agencies: correctly label nonlegislative rules;
publish a list of all rules in the Federal Register; avoid using compulsory
language in nonlegislative rules; explain that nonlegislative rules do
not legally bind either agency employees or individuals; specify that
agencies, courts and the public should not rely on nonlegislative
rules; and remember to use full informal rulemaking process when
creating rules affecting individual rights or obligations. By formally
establishing these principles, Congress and federal agencies will ac-
complish more successfully the APA's auspicious objectives of uni-
formity, fairness and public participation.
JAMES HUNNICUTT
294V4lien it published the GGPs in 1997, the FDA stated it would review them three
years after their implementation. See Good Guidance Practices, 62 Fed. Reg. at 8969.
